Back to Top
         返回页首 

    [Skip to main content](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#main-content)

        ![U.S. flag](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/favicon-57.png)
        
An official website of the United States government美国政府的官方网站

          Here's how you know 以下是您如何知道的 

        ![Dot gov](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/icon-dot-gov.svg)

             **The .gov means it’s official.**             
             Federal government websites often end in .gov or .mil. Before             sharing sensitive information, make sure you’re on a federal             government site.           

        ![Https](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/icon-https.svg)

             **The site is secure.**             
             The **https://** ensures that you are connecting to the             official website and that any information you provide is encrypted             and transmitted securely.           

	

                [!\[NIH NLM Logo\](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/AgencyLogo.svg)](https://www.ncbi.nlm.nih.gov/)

		
			[Log in 登录](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F)															Show account info					

		
			
				
					Close					
#### Account
				
				
					Logged in as:
					**username**				
				
					
- [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/)
- [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/)
- [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/)
- [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F)

				
			
		

	

[Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys)
[NCBI Homepage](https://www.ncbi.nlm.nih.gov/)
[MyNCBI Homepage](https://www.ncbi.nlm.nih.gov/myncbi/)
[Main Content](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#maincontent)
[Main Navigation](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#)

                     **                        Preview improvements coming to the PMC website in October 2024.                        [Learn More](https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/) or                        [Try it out now](https://pmc.ncbi.nlm.nih.gov/articles/PMC9133947/).                    PMC 网站将于 2024 年 10 月推出预览改进。 了解更多信息或立即试用。**                 

                    https://www.ncbi.nlm.nih.gov/pmc/

              Search PMC Full-Text Archive

```

```

                Search in PMC 在 PMC 中搜索 

- [Advanced Search
                         高级搜索](https://www.ncbi.nlm.nih.gov/pmc/advanced)
- [User Guide
                         用户指南](https://www.ncbi.nlm.nih.gov/pmc/about/userguide/)

- [Journal List](https://www.ncbi.nlm.nih.gov/pmc/journals/)
- [JAMA Network](https://www.ncbi.nlm.nih.gov/pmc/?term=%22JAMA%20Network%22[filter])
- PMC9133947

###### Other Formats

- [Printer Friendly](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/?report=printable)

###### Actions

- Cite
- Collections

Add to Collections

    - Create a new collection
    - Add to an existing collection

        Name your collection:

        Name must be less than  characters

        Choose a collection:

        Unable to load your collection due to an error

        [Please try again](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#)

      Add

      Cancel

###### Share

- https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F&amp;text=Development%20and%20Validation%20of%20an%20Explainable%20Machine%20Learning%20Model%20for%20Major%20Complications%20After%20Cytoreductive%20...
- https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F
- Permalink

                                      Copy

###### RESOURCES

- Similar articles
- Cited by other articles
- Links to NCBI Databases

- [Journal List](https://www.ncbi.nlm.nih.gov/pmc/journals/)
- [JAMA Network](https://www.ncbi.nlm.nih.gov/pmc/?term=%22JAMA%20Network%22[filter])
- PMC9133947
期刊列表 JAMA Network PMC9133947

    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.作为一个图书馆，NLM 提供对科学文献的访问。纳入 NLM 数据库并不意味着 NLM 或美国国立卫生研究院认可或同意其内容。

    Learn more:
    [PMC Disclaimer](https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/)
    |
    [PMC Copyright Notice
    了解更多： PMC 免责声明 |           PMC 版权声明](https://www.ncbi.nlm.nih.gov/pmc/about/copyright/)

![Logo of jamasd](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/logo-jamasd.gif)
JAMA Network Open JAMA网络开放 

[JAMA Netw Open.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#) 2022 May; 5(5): e2212930. JAMA Netw 公开赛。 2022年5月;5（5）：e2212930。

Published online 2022 May 25.   doi: [10.1001/jamanetworkopen.2022.12930](https://doi.org/10.1001%2Fjamanetworkopen.2022.12930)2022年5月25日在线发布。 doi： 10.1001/jamanetworkopen.2022.12930

PMCID: PMC9133947 PMCID：PMC9133947 

PMID: [35612856](https://pubmed.ncbi.nlm.nih.gov/35612856) PMID：35612856 

# Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery细胞减灭术后主要并发症的可解释机器学习模型的开发和验证

[Huiyu Deng](https://pubmed.ncbi.nlm.nih.gov/?term=Deng%20H%5BAuthor%5D), PhD,^1^ [Zahra Eftekhari](https://pubmed.ncbi.nlm.nih.gov/?term=Eftekhari%20Z%5BAuthor%5D), MS,^1^ [Cameron Carlin](https://pubmed.ncbi.nlm.nih.gov/?term=Carlin%20C%5BAuthor%5D), MS,^1^ [Jula Veerapong](https://pubmed.ncbi.nlm.nih.gov/?term=Veerapong%20J%5BAuthor%5D), MD,^2^ [Keith F. Fournier](https://pubmed.ncbi.nlm.nih.gov/?term=Fournier%20KF%5BAuthor%5D), MD,^3^ [Fabian M. Johnston](https://pubmed.ncbi.nlm.nih.gov/?term=Johnston%20FM%5BAuthor%5D), MD, MHS,^4^ [Sean P. Dineen](https://pubmed.ncbi.nlm.nih.gov/?term=Dineen%20SP%5BAuthor%5D), MD,^5^ [Benjamin D. Powers](https://pubmed.ncbi.nlm.nih.gov/?term=Powers%20BD%5BAuthor%5D), MD, MS,^5^ [Ryan Hendrix](https://pubmed.ncbi.nlm.nih.gov/?term=Hendrix%20R%5BAuthor%5D), MD,^6^ [Laura A. Lambert](https://pubmed.ncbi.nlm.nih.gov/?term=Lambert%20LA%5BAuthor%5D), MD,^7^ [Daniel E. Abbott](https://pubmed.ncbi.nlm.nih.gov/?term=Abbott%20DE%5BAuthor%5D), MD,^8^ [Kara Vande Walle](https://pubmed.ncbi.nlm.nih.gov/?term=Vande%20Walle%20K%5BAuthor%5D), MD,^8^ [Travis E. Grotz](https://pubmed.ncbi.nlm.nih.gov/?term=Grotz%20TE%5BAuthor%5D), MD,^9^ [Sameer H. Patel](https://pubmed.ncbi.nlm.nih.gov/?term=Patel%20SH%5BAuthor%5D), MD,^10^ [Callisia N. Clarke](https://pubmed.ncbi.nlm.nih.gov/?term=Clarke%20CN%5BAuthor%5D), MD,^11^ [Charles A. Staley](https://pubmed.ncbi.nlm.nih.gov/?term=Staley%20CA%5BAuthor%5D), MD,^12^ [Sherif Abdel-Misih](https://pubmed.ncbi.nlm.nih.gov/?term=Abdel-Misih%20S%5BAuthor%5D), MD,^13^ [Jordan M. Cloyd](https://pubmed.ncbi.nlm.nih.gov/?term=Cloyd%20JM%5BAuthor%5D), MD,^13^ [Byrne Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20B%5BAuthor%5D), MD,^14^ [Yuman Fong](https://pubmed.ncbi.nlm.nih.gov/?term=Fong%20Y%5BAuthor%5D), MD,^1^ and  [Mustafa Raoof](https://pubmed.ncbi.nlm.nih.gov/?term=Raoof%20M%5BAuthor%5D), MD^![corresponding author](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/corrauth.gif)^^1^Huiyu 邓，博士，^1^Zahra Eftekhari，硕士，^1^Cameron Carlin，硕士，^1^Jula Veerapong，医学博士，^2^Keith F. Fournier，医学博士，^3^Fabian M. Johnston，医学博士，MHS，Sean^4^ P. Dineen，医学博士，^5^Benjamin D. Powers，医学博士，MS，Ryan^5^ Hendrix，医学博士，^6^Laura A. Lambert，医学博士，^7^Daniel E. Abbott，医学博士，^8^Kara Vande Walle，医学博士，^8^Travis E. Grotz，医学博士，^9^Sameer H. Patel，医学博士，^10^Callisia N. Clarke， 医学博士、^11^Charles A. Staley 医学博士、^12^Sherif Abdel-Misih 医学博士、^13^Jordan M. Cloyd 医学博士、^13^Byrne Lee 医学博士、^14^Yuman Fong 医学博士和^1^ Mustafa Raoof 医学博士^![corresponding author](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/corrauth.gif)^^1^。

### Huiyu Deng

^1^City of Hope National Medical Center, Duarte, California

Find articles by [Huiyu Deng](https://pubmed.ncbi.nlm.nih.gov/?term=Deng%20H%5BAuthor%5D)

### Zahra Eftekhari

^1^City of Hope National Medical Center, Duarte, California

Find articles by [Zahra Eftekhari](https://pubmed.ncbi.nlm.nih.gov/?term=Eftekhari%20Z%5BAuthor%5D)

### Cameron Carlin

^1^City of Hope National Medical Center, Duarte, California

Find articles by [Cameron Carlin](https://pubmed.ncbi.nlm.nih.gov/?term=Carlin%20C%5BAuthor%5D)

### Jula Veerapong

^2^University of California at San Diego, San Diego

Find articles by [Jula Veerapong](https://pubmed.ncbi.nlm.nih.gov/?term=Veerapong%20J%5BAuthor%5D)

### Keith F. Fournier

^3^MD Anderson Cancer Center, Houston, Texas

Find articles by [Keith F. Fournier](https://pubmed.ncbi.nlm.nih.gov/?term=Fournier%20KF%5BAuthor%5D)

### Fabian M. Johnston

^4^Johns Hopkins University, Baltimore, Maryland

Find articles by [Fabian M. Johnston](https://pubmed.ncbi.nlm.nih.gov/?term=Johnston%20FM%5BAuthor%5D)

### Sean P. Dineen

^5^Moffitt Cancer Center, Tampa, Florida

Find articles by [Sean P. Dineen](https://pubmed.ncbi.nlm.nih.gov/?term=Dineen%20SP%5BAuthor%5D)

### Benjamin D. Powers

^5^Moffitt Cancer Center, Tampa, Florida

Find articles by [Benjamin D. Powers](https://pubmed.ncbi.nlm.nih.gov/?term=Powers%20BD%5BAuthor%5D)

### Ryan Hendrix

^6^University of Massachusetts, Worcester, Massachusetts

Find articles by [Ryan Hendrix](https://pubmed.ncbi.nlm.nih.gov/?term=Hendrix%20R%5BAuthor%5D)

### Laura A. Lambert

^7^University of Utah, Salt Lake City

Find articles by [Laura A. Lambert](https://pubmed.ncbi.nlm.nih.gov/?term=Lambert%20LA%5BAuthor%5D)

### Daniel E. Abbott

^8^University of Wisconsin, Madison

Find articles by [Daniel E. Abbott](https://pubmed.ncbi.nlm.nih.gov/?term=Abbott%20DE%5BAuthor%5D)

### Kara Vande Walle

^8^University of Wisconsin, Madison

Find articles by [Kara Vande Walle](https://pubmed.ncbi.nlm.nih.gov/?term=Vande%20Walle%20K%5BAuthor%5D)

### Travis E. Grotz

^9^Mayo Clinic, Rochester, Minnesota

Find articles by [Travis E. Grotz](https://pubmed.ncbi.nlm.nih.gov/?term=Grotz%20TE%5BAuthor%5D)

### Sameer H. Patel

^10^University of Cincinnati, Cincinnati, Ohio

Find articles by [Sameer H. Patel](https://pubmed.ncbi.nlm.nih.gov/?term=Patel%20SH%5BAuthor%5D)

### Callisia N. Clarke

^11^Medical College of Wisconsin, Milwaukee, Wisconsin

Find articles by [Callisia N. Clarke](https://pubmed.ncbi.nlm.nih.gov/?term=Clarke%20CN%5BAuthor%5D)

### Charles A. Staley

^12^Emory University, Atlanta, Georgia

Find articles by [Charles A. Staley](https://pubmed.ncbi.nlm.nih.gov/?term=Staley%20CA%5BAuthor%5D)

### Sherif Abdel-Misih

^13^Ohio State University, Columbus

Find articles by [Sherif Abdel-Misih](https://pubmed.ncbi.nlm.nih.gov/?term=Abdel-Misih%20S%5BAuthor%5D)

### Jordan M. Cloyd

^13^Ohio State University, Columbus

Find articles by [Jordan M. Cloyd](https://pubmed.ncbi.nlm.nih.gov/?term=Cloyd%20JM%5BAuthor%5D)

### Byrne Lee

^14^Stanford University, Stanford, California

Find articles by [Byrne Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20B%5BAuthor%5D)

### Yuman Fong

^1^City of Hope National Medical Center, Duarte, California

Find articles by [Yuman Fong](https://pubmed.ncbi.nlm.nih.gov/?term=Fong%20Y%5BAuthor%5D)

### Mustafa Raoof

^1^City of Hope National Medical Center, Duarte, California

Find articles by [Mustafa Raoof](https://pubmed.ncbi.nlm.nih.gov/?term=Raoof%20M%5BAuthor%5D)

[Author information](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#) [Article notes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#) [Copyright and License information](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#) [PMC Disclaimer](https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/)作者信息 文章注释 版权和许可信息 PMC 免责声明

^1^City of Hope National Medical Center, Duarte, California

^2^University of California at San Diego, San Diego

^3^MD Anderson Cancer Center, Houston, Texas

^4^Johns Hopkins University, Baltimore, Maryland

^5^Moffitt Cancer Center, Tampa, Florida

^6^University of Massachusetts, Worcester, Massachusetts

^7^University of Utah, Salt Lake City

^8^University of Wisconsin, Madison

^9^Mayo Clinic, Rochester, Minnesota

^10^University of Cincinnati, Cincinnati, Ohio

^11^Medical College of Wisconsin, Milwaukee, Wisconsin

^12^Emory University, Atlanta, Georgia

^13^Ohio State University, Columbus

^14^Stanford University, Stanford, California

^![corresponding author](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/corrauth.gif)^Corresponding author.

Article Information

**Accepted for Publication:** March 31, 2022.

**Published:** May 25, 2022. doi:10.1001/jamanetworkopen.2022.12930

**Open Access:** This is an open access article distributed under the terms of the [CC-BY License](https://jamanetwork.com/pages/cc-by-license-permissions). © 2022 Deng H et al. *JAMA Network Open*.

**Corresponding Author:** Mustafa Raoof, MD, Department of Surgery, Cancer Genetics & Epigenetics, MALP 2229, 1500 E. Duarte Rd, Duarte, CA 91010 ([gro.hoc@fooarm](mailto:dev@null)).

**Author Contributions:** Drs Raoof and Deng had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

*Concept and design:* Eftekhari, Dineen, Powers, Patel, Cloyd, Fong, Raoof.

*Acquisition, analysis, or interpretation of data:* Deng, Eftekhari, Carlin, Veerapong, Fournier, Johnston, Dineen, Hendrix, Lambert, Abbott, Vande Walle, Grotz, Clarke, Staley, Abdel-Misih, Cloyd, Lee, Raoof.

*Drafting of the manuscript:* Deng, Staley, Lee, Fong, Raoof.

*Critical revision of the manuscript for important intellectual content:* Deng, Eftekhari, Carlin, Veerapong, Fournier, Johnston, Dineen, Powers, Hendrix, Lambert, Abbott, Vande Walle, Grotz, Patel, Clarke, Abdel-Misih, Cloyd, Raoof.

*Statistical analysis:* Deng, Eftekhari, Carlin, Raoof.

*Administrative, technical, or material support:* Eftekhari, Fournier, Powers, Lambert, Vande Walle, Patel, Cloyd, Fong, Raoof.

*Supervision:* Eftekhari, Carlin, Veerapong, Powers, Abbott, Grotz, Staley, Lee, Raoof.

**Conflict of Interest Disclosures:** Dr Johnston reported receiving National Institutes of Health funding for work as expert legal reviewer for multiple law firms; he reported receiving grant funding from National Cancer Institute and National Institute on Minority Health and Health Disparities. Dr Fong reported receiving personal fees as scientific advisor from Medtronics, Johnson and Johnson, Iovance, Eureka, Imugene, Xdemics, and Vergent outside the submitted work; and reported royalties received from Merck and Imugene.

Received 2021 Dec 17; Accepted 2022 Mar 31.

[Copyright](https://www.ncbi.nlm.nih.gov/pmc/about/copyright/)  2022 Deng H et al. *JAMA Network Open*.

This is an open access article distributed under the terms of the CC-BY License.

**This article has been corrected. **See [JAMA Netw Open. 2022 June 22; 5(6): e2221574](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218847/).本文已得到更正。 请参阅 JAMA Netw Open。2022年6月22日;5（6）： e2221574 .

## Associated Data 相关数据 

- [Supplementary Materials 补充材料](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#)
    - **Supplement: **
eMethods.

**eFigure 1.** AUROCs and AUPRCs of the Cross-Validation Sets and the Holdout Test Set From the Model Trained With the Entire Training Set

**eFigure 2.** Patients With the Highest, Lowest, and Median SHAP Values

**eFigure 3.** One-way SHAP Dependence Plot of the Top 10 Most Important Predictors

**eTable 1.** List of Variables Incorporated in Risk Models (ie, MLR Model 1)

**eTable 2.** Hyperparameters and Their Tuning Range

**eTable 3.** Comparison of Predictive Performance Between the GBM and Two Multivariate Logistic Regression (MLR) Models

**eTable 4.** Characteristics of the Selected Clusters From the Plot of Local Explanation Embedding (Figure 3)

 eReferences. 

[jamanetwopen-e2212930-s001.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/bin/jamanetwopen-e2212930-s001.pdf) (408K)

GUID: 09E5835F-20A5-454B-B203-1411FEE8AF58

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Key Points 要点 

### Question 问题 

Can machine learning provide superior risk prediction compared with the current statistical methods for patients undergoing cytoreductive surgery?与目前的统计方法相比，机器学习能否为接受细胞减灭术的患者提供更好的风险预测？

### Findings 发现 

In this prognostic study, an optimized machine learning model demonstrated superior capability of predicting individual-level risk of major complications after cytoreductive surgery than traditional methods. Cohort-level risk prediction allowed unbiased categorization of patients into 6 distinct surgical risk groups.在这项预后研究中，优化的机器学习模型显示出比传统方法更能预测细胞减灭手术后主要并发症的个体水平风险的能力。队列水平的风险预测允许将患者无偏倚地分为 6 个不同的手术风险组。

### Meaning 意义 

These results suggest that explainable machine learning methods cannot only provide accurate risk prediction but can also allow identification of potentially modifiable sources of risk on patient and cohort levels.这些结果表明，可解释的机器学习方法不仅可以提供准确的风险预测，而且还可以在患者和队列水平上识别可能可改变的风险源。

## 

This prognostic study of US patients who underwent cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy develops and validates a model for predicting major postoperative complications using machine learning technology.这项针对接受细胞减灭术联合或不联合腹腔热内化疗的美国患者的预后研究开发并验证了一种使用机器学习技术预测主要术后并发症的模型。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Abstract 抽象 

### Importance 重要性 

Cytoreductive surgery (CRS) is one of the most complex operations in surgical oncology with significant morbidity, and improved risk prediction tools are critically needed. Machine learning models can potentially overcome the limitations of traditional multiple logistic regression (MLR) models and provide accurate risk estimates.细胞减灭术 （CRS） 是外科肿瘤学中最复杂的手术之一，发病率很高，迫切需要改进风险预测工具。机器学习模型可以潜在地克服传统多元逻辑回归 （MLR） 模型的局限性，并提供准确的风险估计。

### Objective 目的 

To develop and validate an explainable machine learning model for predicting major postoperative complications in patients undergoing CRS.开发和验证一种可解释的机器学习模型，用于预测接受 CRS 的患者的主要术后并发症。

### Design, Setting, and Participants设计、设置和参与者

This prognostic study used patient data from tertiary care hospitals with expertise in CRS included in the US Hyperthermic Intraperitoneal Chemotherapy Collaborative Database between 1998 and 2018. Information from 147 variables was extracted to predict the risk of a major complication. An ensemble-based machine learning (gradient-boosting) model was optimized on 80% of the sample with subsequent validation on a 20% holdout data set. The machine learning model was compared with traditional MLR models. The artificial intelligence SHAP (Shapley additive explanations) method was used for interpretation of patient- and cohort-level risk estimates and interactions to define novel surgical risk phenotypes. Data were analyzed between November 2019 and August 2021.这项预后研究使用了 1998 年至 2018 年间美国腹腔热化疗协作数据库中包含的具有 CRS 专业知识的三级医院的患者数据。从 147 个变量中提取信息以预测主要并发症的风险。在80%的样本上优化了基于集成的机器学习（梯度提升）模型，随后在20%的维持数据集上进行了验证。将机器学习模型与传统的MLR模型进行了比较。人工智能 SHAP（Shapley 加性解释）方法用于解释患者和队列水平的风险估计和交互作用，以定义新的手术风险表型。数据分析了 2019 年 11 月至 2021 年 8 月期间的数据。

### Exposures 曝光 

Cytoreductive surgery. 细胞修复手术。 

### Main Outcomes and Measures 主要成果和衡量标准 

Area under the receiver operating characteristics (AUROC); area under the precision recall curve (AUPRC).接收者操作特征下面积 (AUROC)；精确召回曲线下面积 (AUPRC)。

### Results 成果 

Data from a total 2372 patients were included in model development (mean age, 55 years [range, 11-95 years]; 1366 [57.6%] women). The optimized machine learning model achieved high discrimination (AUROC: mean cross-validation, 0.75 [range, 0.73-0.81]; test, 0.74) and precision (AUPRC: mean cross-validation, 0.50 [range, 0.46-0.58]; test, 0.42). Compared with the optimized machine learning model, the published MLR model performed worse (test AUROC and AUPRC: 0.54 and 0.18, respectively). Higher volume of estimated blood loss, having pelvic peritonectomy, and longer operative time were the top 3 contributors to the high likelihood of major complications. SHAP dependence plots demonstrated insightful nonlinear interactive associations between predictors and major complications. For instance, high estimated blood loss (ie, above 500 mL) was only detrimental when operative time exceeded 9 hours. Unsupervised clustering of patients based on similarity of sources of risk allowed identification of 6 distinct surgical risk phenotypes.共有 2372 名患者的数据被纳入模型开发（平均年龄 55 岁 [范围 11-95 岁]；女性 1366 人 [57.6%]）。优化后的机器学习模型实现了较高的区分度（AUROC：平均交叉验证，0.75 [范围，0.73-0.81]；测试，0.74）和精确度（AUPRC：平均交叉验证，0.50 [范围，0.46-0.58]；测试，0.42）。与优化的机器学习模型相比，已发表的 MLR 模型表现较差（测试 AUROC 和 AUPRC 分别为 0.54 和 0.18）。估计失血量较高、盆腔腹膜切除术和手术时间较长是导致重大并发症发生可能性较高的前三位因素。SHAP依存图显示了预测因素与主要并发症之间深刻的非线性互动关系。例如，估计失血量高（即超过 500 毫升）只有在手术时间超过 9 小时时才会产生不利影响。根据风险来源的相似性对患者进行无监督聚类，可以识别出 6 种不同的手术风险表型。

### Conclusions and Relevance 结论和相关性 

In this prognostic study using data from patients undergoing CRS, an optimized machine learning model demonstrated a superior ability to predict individual- and cohort-level risk of major complications vs traditional methods. Using the SHAP method, 6 distinct surgical phenotypes were identified based on sources of risk of major complications.在这项利用接受 CRS 的患者数据进行的预后研究中，与传统方法相比，经过优化的机器学习模型在预测个体和队列水平的主要并发症风险方面表现出了卓越的能力。使用 SHAP 方法，根据主要并发症的风险来源确定了 6 种不同的手术表型。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Introduction 导言 

Risk assessment is fundamental to surgical decision-making. A surgeon must weigh the potential benefits of an operation against both the risks and the alternatives. Such risk assessment can inform decision-making and patient counseling. Importantly, if any modifiable sources of risk are known, it may allow opportunities for intervention aimed at risk reduction prior to surgery. Therefore, there is an unmet need to develop tools that improve surgical risk assessment.风险评估是手术决策的基础。外科医生必须权衡手术的潜在益处与风险和替代方案。这种风险评估可以为决策和病人咨询提供依据。重要的是，如果知道任何可改变的风险来源，就有可能在手术前采取旨在降低风险的干预措施。因此，开发改进手术风险评估工具的需求尚未得到满足。

Most surgeons assess risk based on their clinical judgement. While clinical judgement is honed through years of training, interpretation of published data, and patient care experience, there remains an opportunity to augment decision-making through risk prediction tools.^[1](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r1)^ Traditionally, these tools are developed using statistical models, such as linear or logistic regression. However, as the complexity of decision-making increases, these traditional models fall short by failing to account for the complex interactions among predictor variables. This is because traditional models can falsely assume that the variables affecting outcome interact with each other in a linear fashion.^[2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r2)^ This is often not the case, and the consequences of making this assumption can severely limit the utility of the risk-prediction model.^[3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r3)^ Alternatively, recent advances in machine learning may be leveraged to develop improved risk prediction tools, especially for high-complexity surgical decisions.^[4](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r4)^大多数外科医生根据自己的临床判断来评估风险。虽然临床判断是通过多年的培训、对已发表数据的解读和患者护理经验磨练出来的，但仍有机会通过风险预测工具来增强决策。然而，随着决策复杂性的增加，这些传统模型因无法解释预测变量之间复杂的相互作用而存在不足。^[2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r2)^事实往往并非如此，做出这种假设的后果可能会严重限制风险预测模型的实用性。^[3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r3)^另外，可以利用机器学习的最新进展来开发更好的风险预测工具，尤其是针对高复杂性的手术决策。

In machine learning, ensemble methods use multiple learning algorithms to obtain better predictive performance than could be obtained from any of the constituent learning algorithms alone. While ensemble machine learning models achieve the goal of higher predictive performance, they are uninterpretable with regards to the sources of risk, limiting their clinical utility.^[5](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r5)^ Recent advances in explainable artificial intelligence methods can now be used to allow interpretation of ensemble-based machine learning models.^[6](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r6)^ These explainable machine learning models hold a great potential in facilitating clinical application of machine learning in the surgical care of patients.在机器学习中，集合方法使用多种学习算法来获得比任何一种组成学习算法单独使用时更好的预测性能。^[5](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r5)^可解释人工智能方法的最新进展现在可用于解释基于集合的机器学习模型。^[6](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r6)^这些可解释机器学习模型在促进机器学习在患者外科护理中的临床应用方面具有巨大潜力。

The goal of this study was to develop and validate a novel explainable machine learning model using data from patients undergoing cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC). CRS (with or without HIPEC) is one the most complex operations in surgical oncology, with significant morbidity. Our prior work has demonstrated a significant variation in perioperative care for CRS and HIPEC and patient outcomes.^[7](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r7)^ These observations underscore the need for improved risk assessment to not only improve patient selection but also identify areas of perioperative care optimization.本研究的目的是利用接受或未接受腹腔内热化疗（HIPEC）的细胞减毒手术（CRS）患者的数据，开发并验证一种新型的可解释机器学习模型。CRS（伴有或不伴有 HIPEC）是肿瘤外科最复杂的手术之一，发病率很高。^[7](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r7)^这些观察结果突显了改进风险评估的必要性，不仅能改进患者选择，还能确定围手术期护理优化的领域。

We developed an explainable machine learning model to (1) accurately predict individual-level risk of major complications; (2) identify global-level clustering of patients in risk categories to understand what we describe as “surgical phenotypes”; and (3) compare the performance of machine learning models to traditional logistic regression models. Lastly, we describe how this explainable machine learning model can potentially be used in the clinic to identify sources of risk and inform surgical decision-making for patients undergoing CRS and HIPEC.我们开发了一种可解释的机器学习模型，用于：（1）准确预测个体层面的主要并发症风险；（2）识别风险类别中患者的整体聚类，以了解我们所描述的 "手术表型"；以及（3）比较机器学习模型与传统逻辑回归模型的性能。最后，我们介绍了这种可解释的机器学习模型如何在临床中用于识别风险来源，并为接受 CRS 和 HIPEC 的患者的手术决策提供信息。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Methods 方法 

### Data Collection 数据收集 

Data for this study was extracted from the US HIPEC Collaborative database, which consists of retrospectively curated data from a multi-institutional cohort of patients who underwent CRS with or without HIPEC. The US HIPEC Collaborative comprises 12 major academic institutions.^[8](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r8),[9](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r9)^ Each respective institutional review board granted a waiver of informed consent, and data were deidentified. This study followed the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ([TRIPOD](http://www.equator-network.org/reporting-guidelines/tripod-statement/)) reporting guideline for prognostic studies.本研究的数据摘自美国HIPEC协作数据库，该数据库由多机构队列中接受或未接受HIPEC治疗的CRS患者的回顾性数据组成。^[8](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r8),[9](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r9)^每个机构的审查委员会都授予了知情同意豁免权，并对数据进行了去身份化处理。本研究遵循了预后研究多变量预测模型的透明报告指南（TRIPOD）。

### Statistical Analysis 统计分析 

There were a total of 147 predictors (eMethods, eTable 1 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). The primary outcome of interest were complications that were graded as 3 or higher based on the Clavien-Dindo classification system.^[10](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r10)^ To predict these surgical complications, we used an ensemble-based machine learning model, a gradient boosting model (hereafter referred to as GBM) as implemented in the lightGBM package (version 2.3.1) in Python.^[11](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r11)^ The training set contained 80% of included patients. The optimized model was then validated by the independent holdout test set, which contained the remaining 20% of the patients (eMethods in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)).共有 147 个预测因子（电子方法，附录中的电子表格 1）。^[10](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r10)^为了预测这些手术并发症，我们使用了一个基于集合的机器学习模型--梯度提升模型（以下简称GBM），该模型在Python语言的lightGBM软件包（2.3.1版）中实现。优化后的模型通过独立的保留测试集进行验证，测试集包含剩余的 20% 患者（方法见附录）。

Separately, we developed 2 multivariate logistic regression models to predict surgical complications vs no complications. The first model (hereafter referred to as MLR model 1), which included all significant predictors from univariate logistic regression models and excluded the predictors that were highly correlated with each other. The second model (MLR model 2) used the predictors specified from a previously published paper^[12](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r12)^ that predicted surgical complication. These predictors included Charlson Comorbidity Index (excluding the index malignant neoplasm), symptoms, and prior resection and operative status. We then compared predictive performances of these 2 regression models with that of the GBM.另外，我们建立了两个多变量逻辑回归模型来预测手术并发症与无并发症。第一个模型（以下简称 MLR 模型 1）包含了单变量逻辑回归模型中所有重要的预测因子，并排除了相互高度相关的预测因子。第二个模型（MLR 模型 2）使用了之前发表的一篇论文^[12](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r12)^中指定的预测手术并发症的预测因子。这些预测因子包括夏尔森合并症指数（不包括指数恶性肿瘤）、症状、既往切除术和手术状态。然后，我们将这两个回归模型的预测性能与 GBM 的预测性能进行了比较。

To facilitate interpretation of the ensemble-based GBM method we used an artificial intelligence SHAP (Shapley additive explanations) method.^[13](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r13),[14](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r14)^ The SHAP method calculates a total SHAP value for each individual (ie, individual-level total SHAP value), with a higher SHAP value corresponding to a higher likelihood of the target outcome (ie, major complications). To identify surgical phenotypes, patients with similar combinations of individual-level SHAP values were grouped together based on Euclidean distance, an unsupervised distance-based clustering method (eMethods in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)).为了便于解释基于集成的 GBM 方法，我们使用了人工智能 SHAP（Shapley 附加解释）方法。^[13](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r13),[14](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r14)^SHAP 方法计算每个个体的总 SHAP 值（即个体水平总 SHAP 值） ），SHAP 值越高，目标结果（即主要并发症）的可能性就越高。为了识别手术表型，根据欧几里德距离（一种无监督的基于距离的聚类方法）将具有相似个体水平 SHAP 值组合的患者分组在一起（补充中的 eMethods）。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Results 成果 

There were a total of 2372 patients in the study cohort. The mean age of the overall cohort was 55 years (range, 11-95 years), and 1366 (57.6%) were women (研究队列中共有 2372 名患者。整个队列的平均年龄为 55 岁（范围为 11-95 岁），其中 1366 名（57.6%）为女性（[Table 桌子](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/table/zoi220380t1/)). ). 

### Table.  桌子。 

**Selected Baseline and Operative Details选定的基线和操作细节**

| Predictor 预测器 | Patients, No. (%) 患者数（%） |
| --- | --- |
| Age, mean (range), y 年龄，平均值（范围），y | 55 (11-95) 55 (11-95) |
| Sex 性别 |  |
| Men 男士 | 1006 (42.4) 1006 (42.4) |
| Women 女性 | 1366 (57.6) 1366 (57.6) |
| Current smoker 目前吸烟者 | 156 (6.6) 156 (6.6) |
| BMI, median (range) BMI，中位数（范围） | 26.9 (14.4-78.9) 26.9 (14.4-78.9) |
| Albumin, median (range), g/dL 白蛋白，中值（范围），g/dL | 4.1 (0.4-7.5) 4.1 (0.4-7.5) |
| ASA classification of physical healthASA身体健康分类 |  |
| 1 | 10 (0.4) 10 (0.4) |
| 2 | 427 (18.0) 427 (18.0) |
| 3 | 1617 (68.2) 1617 (68.2) |
| 4 | 117 (4.9) 117 (4.9) |
| Missing 丢失的 | 201 (8.5) 201 (8.5) |
| Primary site 主站点 |  |
| Appendiceal | 1524 (64.2) |
| Colorectal | 487 (20.5) |
| Gastric | 43 (1.8) |
| Peritoneal mesothelioma | 174 (7.3) |
| Small bowel | 27 (1.1) |
| Sarcoma | 12 (0.5) |
| Other | 99 (4.1) |
| Missing | 6 (0.2) |
| CEA, mean (range), ng/mL | 244.5 (0.2-82 000) |
| Symptomatic | 1256 (53.0) |
| Prior resection |  |
| None | 1787 (75.3) |
| Yes, without prior CRS and/or HIPEC | 409 (17.2) |
| Yes, with prior CRS and/or HIPEC | 176 (7.4) |
| PCI, mean (range) | 14.6 (0-39) |
| Median operative time (range), h | 7.7 (0-20.8) |
| EBL, median (range) | 456.2 (0-7500) |
| HIPEC | 2038 (85.9) |
| CC score |  |
| 0 (No residual tumor) | 1319 (55.6) |
| 1 (≤2.5 mm) | 539 (22.7) |
| 2 (2.5 mm-2.5 cm) | 165 (7.0) |
| 3 (&gt;2.5 cm) | 166 (7.0) |
| Missing | 183 (7.7) |

[Open in a separate window 在单独的窗口中打开](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/table/zoi220380t1/?report=objectonly)

Abbreviations: ASA, American Society of Anesthesiology; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CC, completeness of cytoreduction; CEA, carcinoembryonic antigen; CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; PCI, peritoneal cancer index.缩写：ASA，美国麻醉学会； BMI，身体质量指数（计算方法为体重公斤数除以身高米数的平方）； CC，细胞减灭术的完整性； CEA，癌胚抗原； CRS，细胞减灭术； HIPEC，腹腔热灌注化疗； PCI，腹膜癌指数。

### Development of Optimized GBM Model优化GBM模型的开发

After splitting the data, there were 1897 patients (80.0%) in the training set, and 475 patients (20.0%) in the test set. Patients with complications grade 3 or higher (ie, major complications) comprised 16% of both the training and the test set. Using the data from the training set, the cross-validation area under the receiver operating characteristics (AUROCs) from the 5 data sets ranged from 0.68 to 0.76 (mean, 0.73), and the cross-validation area under the precision recall curve (AUPRC) ranged from 0.24 to 0.35 (mean, 0.30) (eFigure 1 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). The corresponding mean AUROC and AUPRC of the holdout test set were 0.71 and 0.33, respectively.分割数据后，训练集中有 1897 名患者（80.0%），测试集中有 475 名患者（20.0%）。患有 3 级或以上并发症（即主要并发症）的患者占训练组和测试组的 16%。使用训练集的数据，5个数据集的接收者操作特征（AUROC）下的交叉验证面积范围为0.68至0.76（平均值为0.73），精确召回曲线下的交叉验证面积（AUPRC） ）范围为 0.24 至 0.35（平均值为 0.30）（补充中的 e图 1）。保留测试集相应的平均 AUROC 和 AUPRC 分别为 0.71 和 0.33。

We sought to determine if training the model on patients on the extremes of the outcome (ie, no complication vs complication grade 3 or higher) improved model performance. We reasoned that if the dichotomy was magnified, it would allow for greater accuracy of the optimized GBM model in identifying features of patients with significant complications during training. After excluding patients with grade 1 and 2 complications, there were 1151 patients in the training set; 305 (26.5%) of which had complications that were grade 3 or higher. Indeed, using this subset of the training data, the predictive performances of the model were improved (我们试图确定在极端结果（即无并发症与 3 级或更高级别并发症）的患者上训练模型是否可以提高模型性能。我们推断，如果放大二分法，优化的 GBM 模型在识别训练期间出现严重并发症的患者特征时将具有更高的准确性。排除1级和2级并发症的患者后，训练集中共有1151名患者；其中 305 例 (26.5%) 出现 3 级或以上并发症。事实上，使用训练数据的这个子集，模型的预测性能得到了提高（[Figure 1 图1](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f1/)). The mean cross-validated AUROC and AUPRC increased to 0.75 and 0.50, respectively, and the test AUROC and AUPRC of the same holdout test increased 0.74 and 0.42.）。平均交叉验证的 AUROC 和 AUPRC 分别增加到 0.75 和 0.50，相同保留测试的测试 AUROC 和 AUPRC 增加了 0.74 和 0.42。

[!\[An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g001.jpg\](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/jamanetwopen-e2212930-g001.jpg "An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g001.jpg")](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f1/)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f1/[Open in a separate window](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f1/?report=objectonly)

[Figure 1.  图1。](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f1/)

**AUROCs and AUPRCs of the Cross-Validation Sets and the Holdout Test Set交叉验证集和保留测试集的 AUROC 和 AUPRC**
AUC indicates area under the curve; AUROC, area under the receiver operating characteristics; AUPRC, area under the precision recall curve.AUC表示曲线下面积； AUROC，接收器操作特性下的区域； AUPRC，精确召回曲线下的面积。

### Comparison of Optimized GBM to MLR Models优化的 GBM 与 MLR 模型的比较

To evaluate the predictive performance with the optimized GBM, we also developed 2 MLR models using the same subset of the training data (eTable 3 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). In MLR model 1, 110 predictors were significantly associated with major complications in the univariate models, and were subsequently used to fit this MLR model. Compared with the optimized GBM, the MLR model 1 had a lower test AUROC (optimized GBM, 0.74 vs MLR model 1, 0.71), test AUPRC (optimized GBM, 0.42 vs MLR model 1, 0.34), test true positive rate (optimized GBM, 0.41 vs MLR model 1, 0.35), and test positive predictive rate (optimized GBM, 0.43 vs MLR model 1, 0.39) (eTable 3 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). In the MLR model 2, both CCI and being symptomatic were significant predictors. Compared with the optimized GBM, the MLR model 2 had a much lower test AUROC (MLR model 2, 0.54), test AUPRC (MLR model 2, 0.18), test true positive rate (MLR model 2, 0.38), and test positive predictive rate (MLR model 2, 0.15).为了评估优化 GBM 的预测性能，我们还使用相同的训练数据子集开发了 2 个 MLR 模型（补充材料中的 eTable 3）。在 MLR 模型 1 中，110 个预测变量与单变量模型中的主要并发症显着相关，随后用于拟合该 MLR 模型。与优化的 GBM 相比，MLR 模型 1 的测试 AUROC（优化 GBM，0.74 vs MLR 模型 1，0.71）、测试 AUPRC（优化 GBM，0.42 vs MLR 模型 1，0.34）、测试真阳性率（优化 GBM，0.34）较低。 ，0.41 vs MLR 模型 1，0.35），以及测试阳性预测率（优化 GBM，0.43 vs MLR 模型 1，0.39）（补充中的 eTable 3）。在 MLR 模型 2 中，CCI 和有症状都是重要的预测因子。与优化的 GBM 相比，MLR 模型 2 的测试 AUROC（MLR 模型 2，0.54）、测试 AUPRC（MLR 模型 2，0.18）、测试真阳性率（MLR 模型 2，0.38）和测试阳性预测率显着降低率（MLR 模型 2，0.15）。

### Individual Risk Prediction Using Optimized GBM使用优化 GBM 进行个体风险预测

Risk estimates can be extracted from the optimized GBM by estimating SHAP values to allow interpretation of risk on the patient- or global- level. To better interpret the optimized GBM, we first examined the individual-level risk predictions and their sources of risk specified by the SHAP values using the optimized GBM. For the patient with the highest predicted SHAP value (ie, 0.70), high blood loss (1000 mL), longer operative time (9.37 hours), having pelvic peritonectomy and left diaphragm peritonectomy, and not extubated in OR were the sources of risk that led to the high SHAP value (eFigure 2 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). On the other hand, the patient with the lowest SHAP value (0.06) had low blood loss (150 mL), shorter operative time (6 hours), a high albumin level (4.3 g/dL), and did not have pelvic peritonectomy or partial colectomy. Moreover, for a patient with a moderate SHAP level (0.21), the predictors that contributed to a higher SHAP value (ie, high white blood cell count [10.9 × 10^3^/μL; to convert to × 10^9^ per liter, multiply by 0.001], low albumin [3.3 g/dL; to convert to gallons per liter, multiply by 10], having pelvic peritonectomy) were offset by the predictors that led to a lower SHAP value (low estimated blood loss [EBL] [225 mL], short operative time [5.4 hours], not having partial colectomy).通过估计 SHAP 值，可以从优化的 GBM 中提取风险估计，从而允许在患者或全球层面解释风险。为了更好地解释优化后的GBM，我们首先使用优化的GBM检查了由SHAP值指定的个体水平风险预测及其风险来源。对于预测SHAP值最高（即0.70）、出血量大（1000mL）、手术时间较长（9.37小时）、进行盆腔腹膜切除术和左膈肌腹膜切除术且在手术室未拔管的患者，是导致SHAP值高的风险来源（补充图2）。另一方面，SHAP值最低（0.06）的患者血流量少（150 mL），手术时间短（6小时），白蛋白水平高（4.3 g/dL），未进行盆腔腹膜切除术或结肠部分切除术。此外，对于中等 SHAP 水平 （0.21） 的患者，导致较高 SHAP 值的预测因子（即，高白细胞计数 [10.9 × 10^3^ /μL;转换为 × 10^9^/L，乘以 0.001]、低白蛋白 [3.3 g/dL;转换为加仑/升，乘以 10]，进行盆腔腹膜切除术）被导致较低 SHAP 值的预测因子（低估计血液损失 [EBL] [225 mL]、 手术时间短[5.4小时]，未进行部分结肠切除术）。

### Global Risk Prediction Using Optimized GBM使用优化 GBM 进行全局风险预测

We then evaluated the predictors that contributed to the prediction on a global (ie, patient cohort) level. The SHAP summary plot showed that higher volume of EBL, having pelvic peritonectomy and longer operative (OR) time were the top 3 contributors to the high likelihood of complications grade 3 or higher (然后，我们评估了有助于全球（即患者队列）水平预测的预测因素。 SHAP 总结图显示，较高的 EBL 量、盆腔腹膜切除术和较长的手术 (OR) 时间是导致 3 级或以上并发症可能性较高的前 3 个因素（[Figure 2 图2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/)). SHAP values indicated the relative importance of the predictor variable in determining the outcome. Additionally, having partial colectomy, left diaphragm peritonectomy, older age, and higher percutaneous coronary intervention were also associated with a higher likelihood, while higher albumin, having a resident as the surgical assistant, and being extubated in the OR led to a lower likelihood of complications. We then examined the associations between the predictors and the outcome using the 1-way SHAP dependence plots (eFigure 3 in the ）。 SHAP 值表明预测变量在确定结果时的相对重要性。此外，进行部分结肠切除术、左膈腹膜切除术、年龄较大和较高的经皮冠状动脉介入治疗也与较高的可能性相关，而较高的白蛋白、有住院医师作为手术助理以及在手术室拔管则导致较低的可能性。并发症。然后，我们使用单向 SHAP 依赖图检查了预测变量和结果之间的关联（图 3 中的[Supplement 补充](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). From these plots, we observed the nonlinear associations between EBL and operative time. Specifically, the likelihood of having surgical complications was much higher when EBL was greater than approximately 500 mL and operative time was longer than approximately 9 hours.）。从这些图中，我们观察到 EBL 和手术时间之间的非线性关联。具体来说，当 EBL 大于约 500 mL 且手术时间长于约 9 小时时，出现手术并发症的可能性要高得多。

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/[!\[An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g002.jpg\](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/jamanetwopen-e2212930-g002.jpg "Click on image to zoom")](https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9133947_jamanetwopen-e2212930-g002.jpg)

[Open in a separate window](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/?report=objectonly)

[Figure 2.  图 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/)

**SHAP Summary Plot of the 10 Most Important Predictors10 个最重要的预测因子的 SHAP 汇总图**
For each predictor, the SHAP values for each patient are plotted horizontally, and the magnitude of SHAP values are represented by the x-axis. The importance of the predictors is determined by the predictors’ total SHAP values across all patients (ie, predictor-specific SHAP value). In addition, the values of the predictors are represented by the color: yellow indicates high (or having this condition, if the predictor is binary), green indicates low (or not having this condition). For example, as the EBL increased (from green to yellow), the SHAP values increased, which indicated the likelihood of having complications increased. The binary predictors are pelvic peritonectomy, partial colectomy, left diaphragm peritonectomy, and resident as surgical assistant. EBL indicates estimated blood loss; OR, operative time; PCI, percutaneous coronary intervention; SHAP, Shapley additive explanations. Each point on this plot represents a SHAP value for a predictor and a patient.对于每个预测变量，每个患者的 SHAP 值均水平绘制，SHAP 值的大小由 x 轴表示。预测变量的重要性由所有患者的预测变量总 SHAP 值（即预测变量特定 SHAP 值）决定。此外，预测变量的值用颜色表示：黄色表示高（或具有此条件，如果预测变量是二元的），绿色表示低（或不具有此条件）。例如，随着 EBL 增加（从绿色变为黄色），SHAP 值增加，这表明出现并发症的可能性增加。二元预测因子是盆腔腹膜切除术、部分结肠切除术、左膈腹膜切除术和住院手术助理。 EBL表示估计失血量；或，手术时间； PCI，经皮冠状动脉介入治疗； SHAP，沙普利附加解释。该图上的每个点代表预测变量和患者的 SHAP 值。

### Identification of Surgical Risk Phenotypes and/or Clusters手术风险表型和/或集群的识别

To identify surgical phenotypes that are associated with complications grade 3 or higher, we generated the plot of local explanation embedding (为了识别与 3 级或更高级别并发症相关的手术表型，我们生成了局部解释嵌入图（[Figure 3 图3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/)). This plot demonstrated several clusters of patients with similar characteristics that were associated with the likelihood of complications. For simplicity, we first focused on a cluster of higher SHAP values for EBL and OR time, but lower SHAP values for pelvic peritonectomy (cluster 1). This cluster consisted of 145 patients who had total SHAP values that predicted higher likelihood of complications (mean SHAP for patients in cluster 1, 0.44) (eTable 4 in the ）。该图显示了几组具有相似特征的患者，这些特征与并发症的可能性相关。为简单起见，我们首先关注 EBL 和 OR 时间的较高 SHAP 值集群，但盆腔腹膜切除术的 SHAP 值较低（集群 1）。该聚类由 145 名患者组成，他们的总 SHAP 值预测并发症的可能性较高（聚类 1 中患者的平均 SHAP 为 0.44）（表 4 中的 eTable 4）。[Supplement 补充](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). To better understand the relationship between OR time and EBL within this cluster, we evaluated the SHAP dependence plot (eFigure 4 in the ）。为了更好地理解该簇内 OR 时间和 EBL 之间的关系，我们评估了 SHAP 依赖图（图 4）[Supplement 补充](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s)). This plot demonstrated a threshold effect of EBL on OR time—ie, high EBL was only detrimental when the OR time exceeded 9 hours. We then compared this cluster with 4 other clusters (clusters 3 through 5) in which only 1 association of the predictor was present. When patients only had higher SHAP values for EBL (cluster 3 and 5) or OR time (cluster 4), the predicted probability of having complications was not increased (mean SHAP: cluster 3, 0.25; cluster 5, 0.18; cluster 4, 0.24). Similarly, cluster 2, which consisted of patients with high SHAP values for pelvic peritonectomy but low SHAP values for EBL and OR time, had a relatively high likelihood of the outcome (mean SHAP, 0.34). Next, we focused on a cluster of 162 patients with high SHAP values (mean SHAP, 0.68) that included patients with higher SHAP values for EBL, OR time, pelvic peritonectomy, procedure conducted by a surgical assistant in residency, and extubated in OR (cluster 6). From this cluster, we identified 3 interactions and visualized them using the 2-way dependence plots. Specifically, a higher SHAP value or a higher likelihood of complications was associated with (1) more blood loss with the procedure not performed with a resident as the surgical assistant, (2) pelvic peritonectomy and not extubated in OR, and (3) not extubated in OR with the procedure not performed with a resident as the surgical assistant (）。该图证明了 EBL 对 OR 时间的阈值效应，即，高 EBL 仅当 OR 时间超过 9 小时时才是有害的。然后，我们将该聚类与其他 4 个聚类（聚类 3 到 5）进行比较，其中仅存在 1 个预测变量关联。当患者仅具有较高的 EBL（集群 3 和 5）或 OR 时间（集群 4）SHAP 值时，发生并发症的预测概率不会增加（平均 SHAP：集群 3，0.25；集群 5，0.18；集群 4，0.24 ）。同样，组 2 由盆腔腹膜切除术 SHAP 值高但 EBL 和 OR 时间 SHAP 值低的患者组成，其结果的可能性相对较高（平均 SHAP 为 0.34）。接下来，我们重点关注 162 名具有高 SHAP 值（平均 SHAP 为 0.68）的患者，其中包括 EBL、OR 时间、盆腔腹膜切除术、由住院医师助理进行的手术以及在 OR 中拔管的 SHAP 值较高的患者（集群 6）。从这个集群中，我们确定了 3 种交互作用，并使用 2 路依赖图将它们可视化。具体来说，较高的 SHAP 值或较高的并发症可能性与以下因素相关：(1) 未由住院医师作为外科助理进行的手术导致失血较多；(2) 盆腔腹膜切除术且在手术室中未拔管；(3) 未在手术室中拔管。在手术室拔管，但手术并非由住院医师作为手术助理进行（[Figure 4 图4](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f4/)). ). 

[!\[An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g003.jpg\](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/jamanetwopen-e2212930-g003.jpg "An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g003.jpg")](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/[Open in a separate window](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/?report=objectonly)

[Figure 3.  图 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/)

**Local Explanation Embedding That Identify Clusters of Patients Who Share Similar Characteristics局部解释嵌入可识别具有相似特征的患者群**
The local explanation embedding is presented as a heat map of the individual (ie, patient) SHAP values for each of the 10 most important predictors (局部解释嵌入以 10 个最重要的预测变量中每个变量（即患者）SHAP 值的热图形式呈现（[Figure 2 图2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/)) and is a form of unsupervised distance-based clustering analysis. In this heat map, the patients were grouped based on the “distance” or the similarity between the individual-predictor–specific SHAP values. EBL indicates estimated blood loss; OR, operative time; PCI, percutaneous coronary intervention; SHAP, Shapley additive explanations.），是一种基于无监督距离的聚类分析的形式。在此热图中，患者根据个体预测因子特定 SHAP 值之间的“距离”或相似性进行分组。 EBL表示估计失血量；或，手术时间； PCI，经皮冠状动脉介入治疗； SHAP，沙普利附加解释。

[!\[An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g004.jpg\](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/jamanetwopen-e2212930-g004.jpg "An external file that holds a picture, illustration, etc.
Object name is jamanetwopen-e2212930-g004.jpg")](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f4/)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f4/[Open in a separate window](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f4/?report=objectonly)

[Figure 4.  图 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f4/)

**SHAP Dependence Plot of 4 Predictors of Major Complications With CRSCRS 主要并发症的 4 个预测因子的 SHAP 相关图**
CRS indicates cytoreductive surgery; EBL, estimated blood loss; OR, operative time; SHAP, Shapley additive explanations. Values of the first predictor are represented by the x-axis, and the values of the second predictor are represented by the color: yellow indicates high; green indicates low. SHAP values are represented by the y-axis; for categorial variables, a value of 1 indicates yes and 0 indicates no. To interpret these plots, for example: in panel C, patients with pelvic peritonectomy (x-axis value of 1) and not extubated in OR (green color point) were associated with a higher SHAP value, which indicated a higher likelihood of surgical complications.CRS表示细胞减灭术； EBL，估计失血量；或，手术时间； SHAP，沙普利附加解释。第一个预测变量的值由 x 轴表示，第二个预测变量的值由颜色表示：黄色表示高；绿色表示低。 SHAP 值由 y 轴表示；对于类别变量，值为 1 表示是，值为 0 表示否。为了解释这些图，例如：在图 C 中，盆腔腹膜切除术（x 轴值为 1）且在 OR 中未拔管的患者（绿色点）与较高的 SHAP 值相关，这表明手术并发症的可能性较高。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Discussion 讨论 

In this prognostic study, we developed an ensemble-based machine learning GBM to predict major complications after CRS with or without HIPEC and explored the model’s interpretability using an explainable artificial intelligence SHAP method. This is the first multicenter application of machine learning for risk prediction after CRS and HIPEC.在这项预后研究中，我们开发了一种基于集成的机器学习 GBM，用于预测有或没有 HIPEC 的 CRS 后的主要并发症，并使用可解释的人工智能 SHAP 方法探索了该模型的可解释性。这是继CRS和HIPEC之后机器学习在风险预测方面的首次多中心应用。

To our knowledge, machine learning approaches for risk prediction have not been previously evaluated in a complex surgical setting such as CRS. However, prior application of machine learning to less complex surgical risk predictions have produced promising results.^[3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r3),[15](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r15),[16](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r16),[17](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r17),[18](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r18),[19](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r19)^ Extending these findings in a highly complex patient population, this study demonstrated that optimized GBM had an AUROC and AUPRC of 0.74 and 0.42, respectively, which outperformed traditional logistic regression models. This was because the optimized GBM method was able to account for linear and nonlinear interactions among the predictors. In a single institution study, evaluating risk of complications after CRS using logistic regression,^[12](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r12)^ 42 out of 247 patients had grade 3 or greater complications, and the model had an AUROC of 0.67, which was lower than the present study.据我们所知，用于风险预测的机器学习方法之前尚未在 CRS 等复杂的手术环境中进行过评估。然而，之前将机器学习应用于不太复杂的手术风险预测已经产生了有希望的结果。^[3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r3),[15](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r15),[16](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r16),[17](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r17),[18](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r18),[19](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r19)^将这些发现扩展到高度复杂的患者群体中，本研究表明优化的 GBM 的 AUROC 和 AUPRC 分别为 0.74 和 0.42分别优于传统的逻辑回归模型。这是因为优化的 GBM 方法能够解释预测变量之间的线性和非线性相互作用。在一项单机构研究中，使用逻辑回归评估 CRS 后并发症的风险^[12](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r12)^，247 名患者中有 42 名出现 3 级或以上并发症，模型的 AUROC 为 0.67，低于目前的水平学习。

The multi-institutional design of the study also provides real-world risk estimation for experienced centers. To ensure that the results were reliable we performed rigorous 5-fold internal validation and a subsequent final validation on a holdout unseen set. Furthermore, we ensured that the holdout set composition was similar to the test cohorts so that the validation was not biased due to cohort composition.该研究的多机构设计还为经验丰富的中心提供了现实世界的风险评估。为了确保结果可靠，我们进行了严格的 5 倍内部验证，并随后对未见过的保留集进行了最终验证。此外，我们确保保留集的组成与测试队列相似，以便验证不会因队列组成而产生偏差。

Machine learning models such as the optimized GBM used in this study offer superior risk estimates but are often noninterpretable with respect to the sources of risk. We overcame this issue by visualizing the risk estimates from the optimized GBM model using artificial intelligence–based SHAP values. We identified the top contributors to the risk of surgical complications for individual patients using SHAP force plots as well as for the population using the SHAP summary and dependence plots. As such, this study is one of the most comprehensive clinical applications using the SHAP values. To our knowledge, a few studies have adopted SHAP values to explain their models, but none have included SHAP plots to explain the model both on a local and a global level.^[20](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r20),[21](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r21),[22](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r22),[23](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r23)^ A 2020 study^[20](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r20)^ on predicting acute kidney injury after cardiac surgery used a SHAP summary plot to explain the associations of the top 20 predictors with the outcome on the global level and the nonlinear association of several predictors. Fong et al^[21](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r21)^ used a SHAP dependence plot to explain a 2-way interaction from a model to predict hospital mortality. A third study^[22](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r22)^ also used a SHAP summary plot to explore the top contributing factors that predicted illness severity among COVID-19 patients.机器学习模型（例如本研究中使用的优化 GBM）提供了卓越的风险估计，但通常无法解释风险来源。我们通过使用基于人工智能的 SHAP 值可视化优化 GBM 模型的风险估计来克服这个问题。我们使用 SHAP 力图以及使用 SHAP 总结和依赖图确定了人群手术并发症风险的最大影响因素。因此，这项研究是使用 SHA 值的最全面的临床应用之一。据我们所知，一些研究采用了 SHAP 值来解释其模型，但没有一个研究包含 SHAP 图来解释本地和全球层面的模型。^[20](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r20),[21](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r21),[22](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r22),[23](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r23)^ 2020 年研究 在预测心脏手术后急性肾损伤时，使用 SHAP 汇总图来解释前 20 个预测因子与全局水平结果的关联以及几个预测因子的非线性关联。 Fong 等人^[21](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r21)^ 使用 SHAP 依赖图来解释预测医院死亡率模型的双向交互作用。第三项研究^[22](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r22)^还使用 SHAP 汇总图来探索预测 COVID-19 患者疾病严重程度的主要影响因素。

Many of the top predictors of a major complication identified in this study have been previously reported—including EBL, operative time, colon resection, albumin level, and age (本研究中确定的主要并发症的许多主要预测因素之前已报告过，包括 EBL、手术时间、结肠切除术、白蛋白水平和年龄。[Figure 2 图2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f2/)). ). ^[24](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r24),[25](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r25)^ As such, these observations provide face validity of the optimized GBM. This study identified additional predictors of major complications, including not being extubated in OR, level of surgical assistance, pelvic peritonectomy, and left diaphragm peritonectomy. Importantly, the large cohort of patients included in this study allowed us to accurately rank the relative importance of these factors.因此，这些观察结果提供了优化 GBM 的表面有效性。这项研究确定了主要并发症的其他预测因素，包括手术室中未拔管、手术辅助水平、盆腔腹膜切除术和左膈腹膜切除术。重要的是，这项研究中纳入的大量患者使我们能够准确地对这些因素的相对重要性进行排名。

While our findings provided overall risk estimates for the population, these are unlikely to be useful in the clinical setting. Because of the complex interactions among predictors, factors found to have similar predictive value may have different clinical importance in determining outcome when interacting with each other. A major strength of the SHAP interpretation of the optimized GBM described here is that it provides individual risk estimates (see eFigure 2 in the [Supplement](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1-s) for summaries of 3 examples). Annotation of the relative importance of each favorable and adverse predictor could be used by surgical oncologists to counsel patients about important factors driving the risk of a major complication. At the same time, this insight may provide potential avenues for risk modification.虽然我们的研究结果提供了人群的总体风险估计，但这些在临床环境中不太可能有用。由于预测因素之间存在复杂的相互作用，具有相似预测价值的因素在相互作用时在确定结果时可能具有不同的临床重要性。这里描述的优化 GBM 的 SHAP 解释的一个主要优点是它提供了单独的风险估计（参见补充中的 eFigure 2，了解 3 个示例的摘要）。外科肿瘤学家可以使用每个有利和不利预测因素的相对重要性的注释来向患者提供有关导致主要并发症风险的重要因素的建议。同时，这种见解可能为风险调整提供潜在的途径。

A major limitation of traditional statistical models is that interactions are often ignored or cannot be adequately modeled.^[2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r2)^ The problem is exacerbated as the complexity of clinical scenarios increases, as with the patient population in the present study. The findings presented here highlight the novel use of GBM to account for nonlinear interactions that are not apparent in traditional models. For instance, 2 of the top individual predictors for developing a significant complication (EBL and OR time) had nonlinear interactions associated with the outcome. By visualizing the SHAP plots of feature importance and dependence we discovered a threshold phenomenon in which the risk of surgical complication increased dramatically only when EBL was high (ie, over 500 mL) and OR time exceeded 9 hours.传统统计模型的一个主要限制是交互作用经常被忽略或无法充分建模。^[2](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r2)^随着临床情况复杂性的增加（如本研究中的患者群体），问题会加剧。这里提出的研究结果强调了 GBM 的新颖用途来解释传统模型中不明显的非线性相互作用。例如，发生重大并发症的两个最重要的个体预测因子（EBL 和 OR 时间）与结果具有非线性相互作用。通过可视化特征重要性和依赖性的 SHAP 图，我们发现了一个阈值现象，即只有当 EBL 高（即超过 500 mL）且 OR 时间超过 9 小时时，手术并发症的风险才会急剧增加。

This was also the first study, to our knowledge, that used a machine learning–based method to define what we have described as surgical risk phenotypes based on similar sources of risk. For instance, the plot of local explanation embedding enabled us to visualize patient groups with similar characteristics that contributed to a similar likelihood of surgical complications (据我们所知，这也是第一项使用基于机器学习的方法来定义我们所描述的基于相似风险来源的手术风险表型的研究。例如，局部解释嵌入图使我们能够可视化具有相似特征的患者群体，这些特征导致手术并发症的可能性相似（[Figure 3 图3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/)). This is critical not only for patient counseling but also for the development of optimized perioperative recovery pathways that are personalized, yet standardized.）。这不仅对于患者咨询至关重要，而且对于开发个性化且标准化的优化围手术期恢复途径也至关重要。^[26](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r26)^ Enhanced recovery after surgery (ERAS) pathways have significantly reduced length of stay and perioperative cost of oncological surgery. There is emerging data that indicates ERAS pathways may have value in planning care for patients undergoing CRS with or without HIPEC. It is also known that these patients represent a heterogenous cohort of patients, and a one-size-fits-all approach to the ERAS pathway is unlikely to be successful. An unsupervised clustering analysis identified 6 distinct clusters with varying predicted risk of a major complications (mean SHAP value range, 0.18-0.68) based on sources of risk, as shown in the plot of local explanation embedding (加速康复外科（ERAS）途径显着减少了肿瘤手术的住院时间和围手术期费用。新出现的数据表明，ERAS 途径对于规划接受 CRS（有或没有 HIPEC）的患者的护理可能具有价值。众所周知，这些患者代表了一个异质的患者群体，针对 ERAS 途径的一刀切的方法不太可能成功。无监督聚类分析根据风险来源确定了 6 个不同的聚类，这些聚类具有不同的主要并发症预测风险（平均 SHAP 值范围为 0.18-0.68），如局部解释嵌入图所示（[Figure 3 图3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/figure/zoi220380f3/)). For practical purposes, these clusters could be distilled to a 3-tier system for implementation of risk-stratified ERAS pathways: low-risk category, consisting of unclustered patients (clusters 2 and 4); intermediate-risk category (clusters 1 and 5); and high-risk category (clusters 3 and 6). The best timing for triaging patients into ERAS pathways may be immediately following surgery, as many of the input variables that pertain to operative details are known. A similar approach to risk-stratified ERAS pathways has been demonstrated to be valuable for pancreatic resections.）。出于实际目的，这些集群可以被提炼为 3 层系统，以实施风险分层 ERAS 路径： 低风险类别，由非集群患者（集群 2 和 4）组成；中等风险类别（第 1 类和第 5 类）；和高风险类别（集群 3 和 6）。将患者分类进入 ERAS 途径的最佳时机可能是在手术后立即进行，因为与手术细节相关的许多输入变量都是已知的。风险分层 ERAS 途径的类似方法已被证明对于胰腺切除有价值。^[26](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r26)^

### Limitations 局限性 

This study had several limitations. First, although the optimized GBM model was validated using an unseen holdout set, it would need to be further prospectively validated before widespread adoption. Second, because the model development was based on data from experienced centers, it should be generalized with caution in settings where CRS is not routinely performed. Third, while the model demonstrated moderate discriminative capability, this was far superior to MLR models. Fourth, many of the top predictors were extracted from operative details, which may limit their preoperative use. Almost all patients being considered for CRS and HIPEC are evaluated with contrast-enhanced cross-sectional imaging and/or diagnostic laparoscopy prior to operation. Therefore, surgeons at experienced centers can estimate the likelihood of the extent of resection and infer the input values for the intraoperative variables preoperatively. The optimized GBM model needs to be validated prospectively in this context. Fifth, almost all patients underwent elective curative-intent operations. The findings should be generalized with caution to those undergoing palliative or emergency operations. Finally, adoption of the optimized GBM model in clinical practice as well as integration into electronic medical record will need to be evaluated in future studies.这项研究有几个局限性。首先，虽然优化的 GBM 模型是使用看不见的保留集进行验证的，但在广泛采用之前还需要进一步进行前瞻性验证。其次，由于模型开发是基于经验丰富的中心的数据，因此在不定期进行 CRS 的环境中应谨慎推广。第三，虽然该模型表现出中等的判别能力，但远远优于 MLR 模型。第四，许多最重要的预测因子是从手术细节中提取的，这可能会限制它们的术前使用。几乎所有考虑进行 CRS 和 HIPEC 的患者在手术前都会通过对比增强横断面成像和/或诊断性腹腔镜检查进行评估。因此，经验丰富的中心的外科医生可以在术前估计切除范围的可能性并推断术中变量的输入值。优化的 GBM 模型需要在此背景下进行前瞻性验证。第五，几乎所有患者都接受了择期治疗性手术。研究结果应谨慎推广到那些接受姑息或紧急手术的人。最后，在未来的研究中需要评估优化的 GBM 模型在临床实践中的采用以及与电子病历的集成。

### Conclusion 结论 

The findings of this study demonstrated that an optimized GBM model had a superior predictive performance compared with traditional MLR models for patients undergoing CRS with or without HIPEC. Specifically, we developed and validated an optimized GBM model for accurate risk prediction for a highly complex patient population. Use of SHAP values allowed for interpretability of the optimized GBM, overcoming a major limitation of machine learning models for clinical application. The explanations generated by SHAP plots provide valuable insights into the sources of risk for each individual patient. This information can be used for patient counseling and potential risk modification. We further demonstrated that novel interactions become readily apparent using the SHAP method, which can serve as a valuable research tool for risk mitigation strategies. Finally, on a global level, stratification of patients in different risk categories based on similar sources of risk (what we have described as surgical phenotypes) lays the foundation for future interventional studies focusing on risk-stratified prehabilitation and ERAS pathways.本研究的结果表明，对于接受或不接受 HIPEC 的 CRS 患者，优化的 GBM 模型与传统的 MLR 模型相比具有优越的预测性能。具体来说，我们开发并验证了优化的 GBM 模型，用于对高度复杂的患者群体进行准确的风险预测。 SHAP 值的使用可以解释优化的 GBM，克服了机器学习模型在临床应用中的主要限制。 SHAP 图生成的解释为每个患者的风险来源提供了宝贵的见解。该信息可用于患者咨询和潜在风险调整。我们进一步证明，使用 SHAP 方法，新颖的相互作用变得显而易见，该方法可以作为风险缓解策略的有价值的研究工具。最后，在全球层面上，基于相似风险来源（我们称之为手术表型）对不同风险类别的患者进行分层，为未来关注风险分层预康复和 ERAS 途径的干预研究奠定了基础。

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## Notes 笔记 

#### Supplement. 补充。 

eMethods.
 电子方法。 

**eFigure 1.** AUROCs and AUPRCs of the Cross-Validation Sets and the Holdout Test Set From the Model Trained With the Entire Training Set图 1. 使用整个训练集训练的模型的交叉验证集和保留测试集的 AUROC 和 AUPRC

**eFigure 2.** Patients With the Highest, Lowest, and Median SHAP Valuese图 2. SHA 值最高、最低和中位数的患者

**eFigure 3.** One-way SHAP Dependence Plot of the Top 10 Most Important Predictorse图 3. 前 10 个最重要预测变量的单向 SHAP 相关图

**eTable 1.** List of Variables Incorporated in Risk Models (ie, MLR Model 1)eTable 1. 风险模型（即 MLR 模型 1）中纳入的变量列表

**eTable 2.** Hyperparameters and Their Tuning RangeeTable 2. 超参数及其调整范围

**eTable 3.** Comparison of Predictive Performance Between the GBM and Two Multivariate Logistic Regression (MLR) ModelseTable 3. GBM 与两种多元 Logistic 回归 (MLR) 模型之间的预测性能比较

**eTable 4.** Characteristics of the Selected Clusters From the Plot of Local Explanation Embedding (Figure 3)eTable 4. 局部解释嵌入图中所选簇的特征（图 3）

eReferences.
 电子参考文献。 

[Click here for additional data file.单击此处获取其他数据文件。^(408K, pdf)^。](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/bin/jamanetwopen-e2212930-s001.pdf)^(408K, pdf)^

[Go to: 转到：](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Go to other sections in this page")

## References 参考 

1. Bilimoria KY, Liu Y, Paruch JL, et al.. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833-842. doi: 10.1016/j.jamcollsurg.2013.07.385 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805776/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24055383)] [[CrossRef](https://doi.org/10.1016%2Fj.jamcollsurg.2013.07.385)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Surg&amp;title=Development+and+evaluation+of+the+universal+ACS+NSQIP+surgical+risk+calculator:+a+decision+aid+and+informed+consent+tool+for+patients+and+surgeons&amp;volume=217&amp;issue=5&amp;publication_year=2013&amp;pages=833-842&amp;pmid=24055383&amp;doi=10.1016/j.jamcollsurg.2013.07.385&amp;)]1. Bilimoria KY、Liu Y、Paruch JL 等人。通用 ACS NSQIP 手术风险计算器的开发和评估：患者和外科医生的决策辅助和知情同意工具。  美国大学外科杂志。 2013年； 217（5）：833-842。 doi: 10.1016/j.jamcollsurg.2013.07.385 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

2. Ryo M, Rillig MC. Statistically reinforced machine learning for nonlinear patterns and variable interactions. Ecosphere. 2017;8(11):e01976. doi: 10.1002/ecs2.1976 [[CrossRef](https://doi.org/10.1002%2Fecs2.1976)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ecosphere&amp;title=Statistically+reinforced+machine+learning+for+nonlinear+patterns+and+variable+interactions&amp;volume=8&amp;issue=11&amp;publication_year=2017&amp;pages=e01976&amp;doi=10.1002/ecs2.1976&amp;)]2. Ryo M，Rillig MC。  针对非线性模式和变量交互的统计强化机器学习。  生态圈。 2017年； 8（11）：e01976。 doi: 10.1002/ecs2.1976 [ 交叉引用 ] [ 谷歌学术 ]

3. Bertsimas D, Dunn J, Velmahos GC, Kaafarani HMA. Surgical risk is not linear: derivation and validation of a novel, user-friendly, and machine-learning-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) calculator. Ann Surg. 2018;268(4):574-583. doi: 10.1097/SLA.0000000000002956 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/30124479)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000002956)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Surgical+risk+is+not+linear:+derivation+and+validation+of+a+novel,+user-friendly,+and+machine-learning-based+Predictive+OpTimal+Trees+in+Emergency+Surgery+Risk+%28POTTER%29+calculator&amp;volume=268&amp;issue=4&amp;publication_year=2018&amp;pages=574-583&amp;pmid=30124479&amp;doi=10.1097/SLA.0000000000002956&amp;)]3. Bertsimas D、Dunn J、Velmahos GC、Kaafarani HMA。  手术风险不是线性的：推导和验证一种新颖的、用户友好的、基于机器学习的紧急手术风险预测最优树 (POTTER) 计算器。  安外科医生。 2018； 268（4）：574-583。 doi: 10.1097/SLA.0000000000002956 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

4. Chen JH, Asch SM. Machine learning and prediction in medicine—beyond the peak of inflated expectations. N Engl J Med. 2017;376(26):2507-2509. doi: 10.1056/NEJMp1702071 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953825/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/28657867)] [[CrossRef](https://doi.org/10.1056%2FNEJMp1702071)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Machine+learning+and+prediction+in+medicine%E2%80%94beyond+the+peak+of+inflated+expectations&amp;volume=376&amp;issue=26&amp;publication_year=2017&amp;pages=2507-2509&amp;pmid=28657867&amp;doi=10.1056/NEJMp1702071&amp;)]4. 陈建华，阿希 SM。  医学中的机器学习和预测——超出了夸大的预期的顶峰。  新英格兰医学杂志。 2017年； 376（26）：2507-2509。 doi: 10.1056/NEJMp1702071 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

5. Watson DS, Krutzinna J, Bruce IN, et al.. Clinical applications of machine learning algorithms: beyond the black box. BMJ. 2019;364:l886. doi: 10.1136/bmj.l886 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/30862612)] [[CrossRef](https://doi.org/10.1136%2Fbmj.l886)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Clinical+applications+of+machine+learning+algorithms:+beyond+the+black+box&amp;volume=364&amp;publication_year=2019&amp;pages=l886&amp;pmid=30862612&amp;doi=10.1136/bmj.l886&amp;)]5. Watson DS、Krutzinna J、Bruce IN 等人。机器学习算法的临床应用：超越黑匣子。  英国医学杂志。 2019； 364：l886。 doi: 10.1136/bmj.l886 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

6. El Hechi MW, Nour Eddine SA, Maurer LR, Kaafarani HMA. Leveraging interpretable machine learning algorithms to predict postoperative patient outcomes on mobile devices. Surgery. 2021;169(4):750-754. doi: 10.1016/j.surg.2020.06.049 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32919784)] [[CrossRef](https://doi.org/10.1016%2Fj.surg.2020.06.049)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surgery&amp;title=Leveraging+interpretable+machine+learning+algorithms+to+predict+postoperative+patient+outcomes+on+mobile+devices&amp;volume=169&amp;issue=4&amp;publication_year=2021&amp;pages=750-754&amp;pmid=32919784&amp;doi=10.1016/j.surg.2020.06.049&amp;)]6. El Hechi MW、Nour Eddine SA、Maurer LR、Kaafarani HMA。  利用可解释的机器学习算法在移动设备上预测术后患者的结果。  外科手术 。 2021 年； 169（4）：750-754。 doi: 10.1016/j.surg.2020.06.049 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

7. Eng OS, Blakely AM, Lafaro KJ, et al.. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an opportunity for enhanced recovery pathways. J Surg Oncol. 2020;122(5):980-985. doi: 10.1002/jso.26099 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32627199)] [[CrossRef](https://doi.org/10.1002%2Fjso.26099)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Surg+Oncol&amp;title=Institutional+variation+in+recovery+after+cytoreductive+surgery+and+hyperthermic+intraperitoneal+chemotherapy:+an+opportunity+for+enhanced+recovery+pathways&amp;volume=122&amp;issue=5&amp;publication_year=2020&amp;pages=980-985&amp;pmid=32627199&amp;doi=10.1002/jso.26099&amp;)]7. Eng OS、Blakely AM、Lafaro KJ 等人。细胞减灭手术和腹腔热腹腔化疗后恢复的机构差异：加速恢复途径的机会。  肿瘤外科杂志。 2020； 122（5）：980-985。 doi: 10.1002/jso.26099 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

8. Wiseman JT, Abdel-Misih S, Beal EW, et al.. A multi-institutional analysis of textbook outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol. 2021;37:101492. doi: 10.1016/j.suronc.2020.11.006 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/33465587)] [[CrossRef](https://doi.org/10.1016%2Fj.suronc.2020.11.006)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surg+Oncol&amp;title=A+multi-institutional+analysis+of+textbook+outcomes+among+patients+undergoing+cytoreductive+surgery+for+peritoneal+surface+malignancies&amp;volume=37&amp;publication_year=2021&amp;pages=101492&amp;pmid=33465587&amp;doi=10.1016/j.suronc.2020.11.006&amp;)]8. Wiseman JT、Abdel-Misih S、Beal EW 等人。对接受腹膜表面恶性肿瘤细胞减灭术的患者的教科书结果进行多机构分析。  肿瘤外科。 2021 年； 37：101492。 doi: 10.1016/j.suronc.2020.11.006 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

9. Beal EW, Ahmed A, Grotz T, et al.. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219(3):478-483. doi: 10.1016/j.amjsurg.2019.09.017 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/31558307)] [[CrossRef](https://doi.org/10.1016%2Fj.amjsurg.2019.09.017)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Surg&amp;title=Trends+in+the+indications+for+and+short-term+outcomes+of+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=219&amp;issue=3&amp;publication_year=2020&amp;pages=478-483&amp;pmid=31558307&amp;doi=10.1016/j.amjsurg.2019.09.017&amp;)]9. Beal EW、Ahmed A、Grotz T 等人。细胞减灭术联合热腹腔化疗的适应症和短期结果的趋势。  美国外科杂志。 2020； 219（3）：478-483。 doi: 10.1016/j.amjsurg.2019.09.017 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

10. Clavien PA, Barkun J, de Oliveira ML, et al.. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-196. doi: 10.1097/SLA.0b013e3181b13ca2 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/19638912)] [[CrossRef](https://doi.org/10.1097%2FSLA.0b013e3181b13ca2)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=The+Clavien-Dindo+classification+of+surgical+complications:+five-year+experience&amp;volume=250&amp;issue=2&amp;publication_year=2009&amp;pages=187-196&amp;pmid=19638912&amp;doi=10.1097/SLA.0b013e3181b13ca2&amp;)]10. Clavien PA、Barkun J、de Oliveira ML 等人。手术并发症的 Clavien-Dindo 分类：五年经验。  安外科医生。 2009年； 250（2）：187-196。 doi: 10.1097/SLA.0b013e3181b13ca2 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

11. Ke G, Meng Q, Finley T, et al.. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. In: Guyon I, von Luxburg U, Bengio S, et al., eds. NIPS ’17: Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates; 2017:3149-3157. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=NIPS+%E2%80%9917:+Proceedings+of+the+31st+International+Conference+on+Neural+Information+Processing+Systems&amp;publication_year=2017&amp;)]11. Ke G，Meng Q，Finley T，等人。LightGBM：一种高效的梯度提升决策树。见：Guyon I、von Luxburg U、Bengio S 等编辑。  NIPS ’17：第 31 届神经信息处理系统国际会议论文集。柯伦联营公司； 2017：3149-3157。  [ 谷歌学术 ]

12. Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1609-1617. doi: 10.1245/s10434-015-5012-3 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841914/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/26678406)] [[CrossRef](https://doi.org/10.1245%2Fs10434-015-5012-3)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=A+novel+tool+for+predicting+major+complications+after+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=23&amp;issue=5&amp;publication_year=2016&amp;pages=1609-1617&amp;pmid=26678406&amp;doi=10.1245/s10434-015-5012-3&amp;)]12. 鲍姆加特纳 JM、邝 TG、马 GL、梅塞尔 K、凯利 KJ、洛伊 AM。  一种预测细胞减灭手术和腹腔热灌注化疗后主要并发症的新工具。  安·外科肿瘤学家。 2016年； 23（5）：1609-1617。 doi: 10.1245/s10434-015-5012-3 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

13. Lundberg SM, Lee S-I. A Unified Approach to Interpreting Model Predictions. In: Guyon I, von Luxburg U, Bengio S, et al., eds. NIPS ’17: Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates; 2017:4765-4774. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=NIPS+%E2%80%9917:+Proceedings+of+the+31st+International+Conference+on+Neural+Information+Processing+Systems&amp;publication_year=2017&amp;)]13.伦德伯格 SM，李 S-I。解释模型预测的统一方法。见：Guyon I、von Luxburg U、Bengio S 等编辑。  NIPS ’17：第 31 届神经信息处理系统国际会议论文集。柯伦联营公司； 2017：4765-4774。  [ 谷歌学术 ]

14. Lundberg SM, Erion GG, Lee S-I. Consistent individualized feature attribution for tree ensembles. arXiv. Preprint posted online March 7, 2019. doi: 10.48550/arXiv.1802.03888 [[CrossRef](https://doi.org/10.48550%2FarXiv.1802.03888)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=arXiv&amp;title=Consistent+individualized+feature+attribution+for+tree+ensembles&amp;publication_year=2019&amp;doi=10.48550/arXiv.1802.03888&amp;)]14. Lundberg SM，Erion GG，Lee S-I。  树集成的一致个性化特征归因。  arXiv .预印本于 2019 年 3 月 7 日在线发布。doi：10.48550/arXiv.1802.03888 [ CrossRef ] [ Google Scholar ]

15. Hofer IS, Lee C, Gabel E, Baldi P, Cannesson M. Development and validation of a deep neural network model to predict postoperative mortality, acute kidney injury, and reintubation using a single feature set. NPJ Digit Med. 2020;3(1):58. doi: 10.1038/s41746-020-0248-0 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170922/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32352036)] [[CrossRef](https://doi.org/10.1038%2Fs41746-020-0248-0)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=NPJ+Digit+Med&amp;title=Development+and+validation+of+a+deep+neural+network+model+to+predict+postoperative+mortality,+acute+kidney+injury,+and+reintubation+using+a+single+feature+set&amp;volume=3&amp;issue=1&amp;publication_year=2020&amp;pages=58&amp;pmid=32352036&amp;doi=10.1038/s41746-020-0248-0&amp;)]15. Hofer IS、Lee C、Gabel E、Baldi P、Cannesson M。使用单一特征集预测术后死亡率、急性肾损伤和再插管的深度神经网络模型的开发和验证。  NPJ 数字医学。 2020； 3（1）：58。 doi: 10.1038/s41746-020-0248-0 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

16. FitzHenry F, Murff HJ, Matheny ME, et al.. Exploring the frontier of electronic health record surveillance: the case of postoperative complications. Med Care. 2013;51(6):509-516. doi: 10.1097/MLR.0b013e31828d1210 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658153/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/23673394)] [[CrossRef](https://doi.org/10.1097%2FMLR.0b013e31828d1210)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med+Care&amp;title=Exploring+the+frontier+of+electronic+health+record+surveillance:+the+case+of+postoperative+complications&amp;volume=51&amp;issue=6&amp;publication_year=2013&amp;pages=509-516&amp;pmid=23673394&amp;doi=10.1097/MLR.0b013e31828d1210&amp;)]16. FitzHenry F、Murff HJ、Matheny ME 等人。探索电子健康记录监控的前沿：术后并发症的案例。  医疗护理。 2013年； 51（6）：509-516。 doi: 10.1097/MLR.0b013e31828d1210 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

17. Weller GB, Lovely J, Larson DW, Earnshaw BA, Huebner M. Leveraging electronic health records for predictive modeling of post-surgical complications. Stat Methods Med Res. 2018;27(11):3271-3285. doi: 10.1177/0962280217696115 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29298612)] [[CrossRef](https://doi.org/10.1177%2F0962280217696115)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Stat+Methods+Med+Res&amp;title=Leveraging+electronic+health+records+for+predictive+modeling+of+post-surgical+complications&amp;volume=27&amp;issue=11&amp;publication_year=2018&amp;pages=3271-3285&amp;pmid=29298612&amp;doi=10.1177/0962280217696115&amp;)]17. Weller GB、Lovely J、Larson DW、Earnshaw BA、Huebner M。利用电子健康记录对术后并发症进行预测建模。  统计方法医学研究。 2018； 27（11）：3271-3285。 doi: 10.1177/0962280217696115 [ PubMed ] [ CrossRef ] [ 谷歌学术 ]

18. Maurer LR, Chetlur P, Zhuo D, et al.. Validation of the AI-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) calculator in patients 65 years and older. Ann Surg. Published online December 23, 2020. doi: 10.1097/SLA.0000000000004714 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/33378309)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000004714)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Validation+of+the+AI-based+Predictive+OpTimal+Trees+in+Emergency+Surgery+Risk+%28POTTER%29+calculator+in+patients+65+years+and+older&amp;publication_year=2020&amp;doi=10.1097/SLA.0000000000004714&amp;)]18. Maurer LR、Chetlur P、Zhuo D 等人。在 65 岁及以上患者中验证基于人工智能的紧​​急手术风险预测最优树 (POTTER) 计算器。  安外科医生。 2020 年 12 月 23 日在线发布。doi：10.1097/SLA.0000000000004714 [ PubMed ] [ CrossRef ] [ Google Scholar ]

19. Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al.. MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Ann Surg. 2019;269(4):652-662. doi: 10.1097/SLA.0000000000002706 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110979/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29489489)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000002706)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=MySurgeryRisk:+development+and+validation+of+a+machine-learning+risk+algorithm+for+major+complications+and+death+after+surgery&amp;volume=269&amp;issue=4&amp;publication_year=2019&amp;pages=652-662&amp;pmid=29489489&amp;doi=10.1097/SLA.0000000000002706&amp;)]19. Bihorac A、Ozrazgat-Baslanti T、Ebadi A 等人。MySurgeryRisk：针对术后主要并发症和死亡的机器学习风险算法的开发和验证。  安外科医生。 2019； 269（4）：652-662。 doi: 10.1097/SLA.0000000000002706 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

20. Tseng P-Y, Chen Y-T, Wang C-H, et al.. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24(1):478. doi: 10.1186/s13054-020-03179-9 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395374/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32736589)] [[CrossRef](https://doi.org/10.1186%2Fs13054-020-03179-9)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Prediction+of+the+development+of+acute+kidney+injury+following+cardiac+surgery+by+machine+learning&amp;volume=24&amp;issue=1&amp;publication_year=2020&amp;pages=478&amp;pmid=32736589&amp;doi=10.1186/s13054-020-03179-9&amp;)]20. Tseng P-Y，Chen Y-T，Wang C-H，等。通过机器学习预测心脏手术后急性肾损伤的发展。  紧急护理。 2020； 24（1）：478。 doi: 10.1186/s13054-020-03179-9 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

21. Fong KM, Au SY, Ng GWY, Leung AKH. Interpretable machine learning model for mortality prediction in ICU: a multicenter study. Research Square. Preprint posted online October 1, 2020. doi: 10.21203/rs.3.rs-83283/v1 [[CrossRef](https://doi.org/10.21203%2Frs.3.rs-83283%2Fv1)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Research+Square&amp;title=Interpretable+machine+learning+model+for+mortality+prediction+in+ICU:+a+multicenter+study&amp;publication_year=2020&amp;doi=10.21203/rs.3.rs-83283/v1&amp;)]21. 方健明、欧诗怡、吴桂威、梁安康。  用于 ICU 死亡率预测的可解释机器学习模型：一项多中心研究。  研究广场。预印本于 2020 年 10 月 1 日在线发布。doi：10.21203/rs.3.rs-83283/v1 [ CrossRef ] [ Google Scholar ]

22. Quiroz JC, Feng Y-Z, Cheng Z-Y, et al.. Severity assessment of COVID-19 based on clinical and imaging data. medRxiv. Preprint posted online August 14, 2020. doi: 10.1101/2020.08.12.20173872 [[CrossRef](https://doi.org/10.1101%2F2020.08.12.20173872)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=medRxiv&amp;title=Severity+assessment+of+COVID-19+based+on+clinical+and+imaging+data&amp;publication_year=2020&amp;doi=10.1101/2020.08.12.20173872&amp;)]22. Quiroz JC、Feng Y-Z、Cheng Z-Y 等人。基于临床和影像数据的 COVID-19 严重程度评估。  medRxiv 。预印本于 2020 年 8 月 14 日在线发布。doi：10.1101/2020.08.12.20173872 [ CrossRef ] [ Google Scholar ]

23. Maritsch M, Lehmann V, Kraus M, et al.. Towards Wearable-based Hypoglycemia Detection and Warning in Diabetes. In: CHI EA '20: Extended Abstracts of the 2020 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery; 2020:1-8. doi: 10.1145/3334480.3382808 [[CrossRef](https://doi.org/10.1145%2F3334480.3382808)] [[Google Scholar](https://scholar.google.com/scholar_lookup?title=CHI+EA+%2720:+Extended+Abstracts+of+the+2020+CHI+Conference+on+Human+Factors+in+Computing+Systems&amp;publication_year=2020&amp;)]23. Maritsch M、Lehmann V、Kraus M 等人。致力于糖尿病中基于可穿戴设备的低血糖检测和警告。见：CHI EA '20：2020 年 CHI 计算系统中人为因素会议的扩展摘要。计算机协会； 2020：1-8。 doi: 10.1145/3334480.3382808 [ 交叉引用 ] [ 谷歌学术 ]

24. Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7(1):99-111. [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754303/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/26941988)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Gastrointest+Oncol&amp;title=Cytoreductive+surgery+and+hyperthermic+intraperitoneal+chemotherapy:+a+review+of+factors+contributing+to+morbidity+and+mortality&amp;volume=7&amp;issue=1&amp;publication_year=2016&amp;pages=99-111&amp;pmid=26941988&amp;)]24. 牛顿 AD，巴特利特 EK，卡拉库西斯 GC。  细胞减灭手术和腹腔热灌注化疗：对导致发病率和死亡率的因素的回顾。  J Gastrointest Oncol。 2016年； 7（1）：99-111。  [ PMC 免费文章 ] [ PubMed ] [ Google Scholar ]

25. Eng OS, Dumitra S, O’Leary M, et al.. Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2017;152(12):1156-1160. doi: 10.1001/jamasurg.2017.2865 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831441/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/28832866)] [[CrossRef](https://doi.org/10.1001%2Fjamasurg.2017.2865)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Surg&amp;title=Association+of+fluid+administration+with+morbidity+in+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=152&amp;issue=12&amp;publication_year=2017&amp;pages=1156-1160&amp;pmid=28832866&amp;doi=10.1001/jamasurg.2017.2865&amp;)]25. Eng OS、Dumitra S、O’Leary M 等人。输液与热腹腔化疗细胞减灭术中发病率的关联。  JAMA 外科医师。 2017年； 152（12）：1156-1160。 doi: 10.1001/jamasurg.2017.2865 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

26. Denbo JW, Bruno M, Dewhurst W, et al.. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018;164(3):424-431. doi: 10.1016/j.surg.2018.04.014 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265789/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29807648)] [[CrossRef](https://doi.org/10.1016%2Fj.surg.2018.04.014)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surgery&amp;title=Risk-stratified+clinical+pathways+decrease+the+duration+of+hospitalization+and+costs+of+perioperative+care+after+pancreatectomy&amp;volume=164&amp;issue=3&amp;publication_year=2018&amp;pages=424-431&amp;pmid=29807648&amp;doi=10.1016/j.surg.2018.04.014&amp;)]26. Denbo JW、Bruno M、Dewhurst W 等人。风险分层临床路径可减少胰腺切除术后的住院时间和围手术期护理费用。  外科手术 。 2018； 164（3）：424-431。 doi: 10.1016/j.surg.2018.04.014 [ PMC 免费文章 ] [ PubMed ] [ CrossRef ] [ Google Scholar ]

- [Key Points](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#abstract-a.j.b.aftitle)
- [Abstract](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#abstract-a.j.b.ahtitle)
- [Introduction](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#H1-1-ZOI220380title)
- [Methods](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#H1-2-ZOI220380title)
- [Results](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#H1-3-ZOI220380title)
- [Discussion](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#H1-4-ZOI220380title)
- [Notes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#note-ZOI220380-1title)
- [References](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#REF-ZOI220380title)

* * *

Articles from JAMA Network Open are provided here courtesy of **American Medical Association**此处提供来自 JAMA Network Open 的文章，由美国医学会提供

* * *

1. Bilimoria KY, Liu Y, Paruch JL, et al.. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833-842. doi: 10.1016/j.jamcollsurg.2013.07.385 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805776/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/24055383)] [[CrossRef](https://doi.org/10.1016%2Fj.jamcollsurg.2013.07.385)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Surg&amp;title=Development+and+evaluation+of+the+universal+ACS+NSQIP+surgical+risk+calculator:+a+decision+aid+and+informed+consent+tool+for+patients+and+surgeons&amp;volume=217&amp;issue=5&amp;publication_year=2013&amp;pages=833-842&amp;pmid=24055383&amp;doi=10.1016/j.jamcollsurg.2013.07.385&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r1)]

2. Ryo M, Rillig MC. Statistically reinforced machine learning for nonlinear patterns and variable interactions. Ecosphere. 2017;8(11):e01976. doi: 10.1002/ecs2.1976 [[CrossRef](https://doi.org/10.1002%2Fecs2.1976)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ecosphere&amp;title=Statistically+reinforced+machine+learning+for+nonlinear+patterns+and+variable+interactions&amp;volume=8&amp;issue=11&amp;publication_year=2017&amp;pages=e01976&amp;doi=10.1002/ecs2.1976&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r2)]

3. Bertsimas D, Dunn J, Velmahos GC, Kaafarani HMA. Surgical risk is not linear: derivation and validation of a novel, user-friendly, and machine-learning-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) calculator. Ann Surg. 2018;268(4):574-583. doi: 10.1097/SLA.0000000000002956 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/30124479)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000002956)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Surgical+risk+is+not+linear:+derivation+and+validation+of+a+novel,+user-friendly,+and+machine-learning-based+Predictive+OpTimal+Trees+in+Emergency+Surgery+Risk+%28POTTER%29+calculator&amp;volume=268&amp;issue=4&amp;publication_year=2018&amp;pages=574-583&amp;pmid=30124479&amp;doi=10.1097/SLA.0000000000002956&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r3)]

4. Chen JH, Asch SM. Machine learning and prediction in medicine—beyond the peak of inflated expectations. N Engl J Med. 2017;376(26):2507-2509. doi: 10.1056/NEJMp1702071 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953825/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/28657867)] [[CrossRef](https://doi.org/10.1056%2FNEJMp1702071)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Machine+learning+and+prediction+in+medicine%E2%80%94beyond+the+peak+of+inflated+expectations&amp;volume=376&amp;issue=26&amp;publication_year=2017&amp;pages=2507-2509&amp;pmid=28657867&amp;doi=10.1056/NEJMp1702071&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r4)]

5. Watson DS, Krutzinna J, Bruce IN, et al.. Clinical applications of machine learning algorithms: beyond the black box. BMJ. 2019;364:l886. doi: 10.1136/bmj.l886 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/30862612)] [[CrossRef](https://doi.org/10.1136%2Fbmj.l886)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Clinical+applications+of+machine+learning+algorithms:+beyond+the+black+box&amp;volume=364&amp;publication_year=2019&amp;pages=l886&amp;pmid=30862612&amp;doi=10.1136/bmj.l886&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r5)]

6. El Hechi MW, Nour Eddine SA, Maurer LR, Kaafarani HMA. Leveraging interpretable machine learning algorithms to predict postoperative patient outcomes on mobile devices. Surgery. 2021;169(4):750-754. doi: 10.1016/j.surg.2020.06.049 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32919784)] [[CrossRef](https://doi.org/10.1016%2Fj.surg.2020.06.049)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surgery&amp;title=Leveraging+interpretable+machine+learning+algorithms+to+predict+postoperative+patient+outcomes+on+mobile+devices&amp;volume=169&amp;issue=4&amp;publication_year=2021&amp;pages=750-754&amp;pmid=32919784&amp;doi=10.1016/j.surg.2020.06.049&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r6)]

7. Eng OS, Blakely AM, Lafaro KJ, et al.. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an opportunity for enhanced recovery pathways. J Surg Oncol. 2020;122(5):980-985. doi: 10.1002/jso.26099 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32627199)] [[CrossRef](https://doi.org/10.1002%2Fjso.26099)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Surg+Oncol&amp;title=Institutional+variation+in+recovery+after+cytoreductive+surgery+and+hyperthermic+intraperitoneal+chemotherapy:+an+opportunity+for+enhanced+recovery+pathways&amp;volume=122&amp;issue=5&amp;publication_year=2020&amp;pages=980-985&amp;pmid=32627199&amp;doi=10.1002/jso.26099&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r7)]

8. Wiseman JT, Abdel-Misih S, Beal EW, et al.. A multi-institutional analysis of textbook outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol. 2021;37:101492. doi: 10.1016/j.suronc.2020.11.006 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/33465587)] [[CrossRef](https://doi.org/10.1016%2Fj.suronc.2020.11.006)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surg+Oncol&amp;title=A+multi-institutional+analysis+of+textbook+outcomes+among+patients+undergoing+cytoreductive+surgery+for+peritoneal+surface+malignancies&amp;volume=37&amp;publication_year=2021&amp;pages=101492&amp;pmid=33465587&amp;doi=10.1016/j.suronc.2020.11.006&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r8)]

9. Beal EW, Ahmed A, Grotz T, et al.. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219(3):478-483. doi: 10.1016/j.amjsurg.2019.09.017 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/31558307)] [[CrossRef](https://doi.org/10.1016%2Fj.amjsurg.2019.09.017)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Surg&amp;title=Trends+in+the+indications+for+and+short-term+outcomes+of+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=219&amp;issue=3&amp;publication_year=2020&amp;pages=478-483&amp;pmid=31558307&amp;doi=10.1016/j.amjsurg.2019.09.017&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r9)]

10. Clavien PA, Barkun J, de Oliveira ML, et al.. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-196. doi: 10.1097/SLA.0b013e3181b13ca2 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/19638912)] [[CrossRef](https://doi.org/10.1097%2FSLA.0b013e3181b13ca2)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=The+Clavien-Dindo+classification+of+surgical+complications:+five-year+experience&amp;volume=250&amp;issue=2&amp;publication_year=2009&amp;pages=187-196&amp;pmid=19638912&amp;doi=10.1097/SLA.0b013e3181b13ca2&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r10)]

11. Ke G, Meng Q, Finley T, et al.. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. In: Guyon I, von Luxburg U, Bengio S, et al., eds. NIPS ’17: Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates; 2017:3149-3157. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=NIPS+%E2%80%9917:+Proceedings+of+the+31st+International+Conference+on+Neural+Information+Processing+Systems&amp;publication_year=2017&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r11)]

12. Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1609-1617. doi: 10.1245/s10434-015-5012-3 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841914/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/26678406)] [[CrossRef](https://doi.org/10.1245%2Fs10434-015-5012-3)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=A+novel+tool+for+predicting+major+complications+after+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=23&amp;issue=5&amp;publication_year=2016&amp;pages=1609-1617&amp;pmid=26678406&amp;doi=10.1245/s10434-015-5012-3&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r12)]

13. Lundberg SM, Lee S-I. A Unified Approach to Interpreting Model Predictions. In: Guyon I, von Luxburg U, Bengio S, et al., eds. NIPS ’17: Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates; 2017:4765-4774. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=NIPS+%E2%80%9917:+Proceedings+of+the+31st+International+Conference+on+Neural+Information+Processing+Systems&amp;publication_year=2017&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r13)]

14. Lundberg SM, Erion GG, Lee S-I. Consistent individualized feature attribution for tree ensembles. arXiv. Preprint posted online March 7, 2019. doi: 10.48550/arXiv.1802.03888 [[CrossRef](https://doi.org/10.48550%2FarXiv.1802.03888)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=arXiv&amp;title=Consistent+individualized+feature+attribution+for+tree+ensembles&amp;publication_year=2019&amp;doi=10.48550/arXiv.1802.03888&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r14)]

15. Hofer IS, Lee C, Gabel E, Baldi P, Cannesson M. Development and validation of a deep neural network model to predict postoperative mortality, acute kidney injury, and reintubation using a single feature set. NPJ Digit Med. 2020;3(1):58. doi: 10.1038/s41746-020-0248-0 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170922/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32352036)] [[CrossRef](https://doi.org/10.1038%2Fs41746-020-0248-0)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=NPJ+Digit+Med&amp;title=Development+and+validation+of+a+deep+neural+network+model+to+predict+postoperative+mortality,+acute+kidney+injury,+and+reintubation+using+a+single+feature+set&amp;volume=3&amp;issue=1&amp;publication_year=2020&amp;pages=58&amp;pmid=32352036&amp;doi=10.1038/s41746-020-0248-0&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r15)]

16. FitzHenry F, Murff HJ, Matheny ME, et al.. Exploring the frontier of electronic health record surveillance: the case of postoperative complications. Med Care. 2013;51(6):509-516. doi: 10.1097/MLR.0b013e31828d1210 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658153/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/23673394)] [[CrossRef](https://doi.org/10.1097%2FMLR.0b013e31828d1210)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med+Care&amp;title=Exploring+the+frontier+of+electronic+health+record+surveillance:+the+case+of+postoperative+complications&amp;volume=51&amp;issue=6&amp;publication_year=2013&amp;pages=509-516&amp;pmid=23673394&amp;doi=10.1097/MLR.0b013e31828d1210&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r16)]

17. Weller GB, Lovely J, Larson DW, Earnshaw BA, Huebner M. Leveraging electronic health records for predictive modeling of post-surgical complications. Stat Methods Med Res. 2018;27(11):3271-3285. doi: 10.1177/0962280217696115 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29298612)] [[CrossRef](https://doi.org/10.1177%2F0962280217696115)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Stat+Methods+Med+Res&amp;title=Leveraging+electronic+health+records+for+predictive+modeling+of+post-surgical+complications&amp;volume=27&amp;issue=11&amp;publication_year=2018&amp;pages=3271-3285&amp;pmid=29298612&amp;doi=10.1177/0962280217696115&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r17)]

18. Maurer LR, Chetlur P, Zhuo D, et al.. Validation of the AI-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) calculator in patients 65 years and older. Ann Surg. Published online December 23, 2020. doi: 10.1097/SLA.0000000000004714 [[PubMed](https://pubmed.ncbi.nlm.nih.gov/33378309)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000004714)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Validation+of+the+AI-based+Predictive+OpTimal+Trees+in+Emergency+Surgery+Risk+%28POTTER%29+calculator+in+patients+65+years+and+older&amp;publication_year=2020&amp;doi=10.1097/SLA.0000000000004714&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r18)]

19. Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al.. MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Ann Surg. 2019;269(4):652-662. doi: 10.1097/SLA.0000000000002706 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110979/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29489489)] [[CrossRef](https://doi.org/10.1097%2FSLA.0000000000002706)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=MySurgeryRisk:+development+and+validation+of+a+machine-learning+risk+algorithm+for+major+complications+and+death+after+surgery&amp;volume=269&amp;issue=4&amp;publication_year=2019&amp;pages=652-662&amp;pmid=29489489&amp;doi=10.1097/SLA.0000000000002706&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r19)]

20. Tseng P-Y, Chen Y-T, Wang C-H, et al.. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24(1):478. doi: 10.1186/s13054-020-03179-9 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395374/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/32736589)] [[CrossRef](https://doi.org/10.1186%2Fs13054-020-03179-9)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Prediction+of+the+development+of+acute+kidney+injury+following+cardiac+surgery+by+machine+learning&amp;volume=24&amp;issue=1&amp;publication_year=2020&amp;pages=478&amp;pmid=32736589&amp;doi=10.1186/s13054-020-03179-9&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r20)]

21. Fong KM, Au SY, Ng GWY, Leung AKH. Interpretable machine learning model for mortality prediction in ICU: a multicenter study. Research Square. Preprint posted online October 1, 2020. doi: 10.21203/rs.3.rs-83283/v1 [[CrossRef](https://doi.org/10.21203%2Frs.3.rs-83283%2Fv1)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Research+Square&amp;title=Interpretable+machine+learning+model+for+mortality+prediction+in+ICU:+a+multicenter+study&amp;publication_year=2020&amp;doi=10.21203/rs.3.rs-83283/v1&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r21)]

22. Quiroz JC, Feng Y-Z, Cheng Z-Y, et al.. Severity assessment of COVID-19 based on clinical and imaging data. medRxiv. Preprint posted online August 14, 2020. doi: 10.1101/2020.08.12.20173872 [[CrossRef](https://doi.org/10.1101%2F2020.08.12.20173872)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=medRxiv&amp;title=Severity+assessment+of+COVID-19+based+on+clinical+and+imaging+data&amp;publication_year=2020&amp;doi=10.1101/2020.08.12.20173872&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r22)]

23. Maritsch M, Lehmann V, Kraus M, et al.. Towards Wearable-based Hypoglycemia Detection and Warning in Diabetes. In: CHI EA '20: Extended Abstracts of the 2020 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery; 2020:1-8. doi: 10.1145/3334480.3382808 [[CrossRef](https://doi.org/10.1145%2F3334480.3382808)] [[Google Scholar](https://scholar.google.com/scholar_lookup?title=CHI+EA+%2720:+Extended+Abstracts+of+the+2020+CHI+Conference+on+Human+Factors+in+Computing+Systems&amp;publication_year=2020&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r23)]

24. Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7(1):99-111. [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754303/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/26941988)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Gastrointest+Oncol&amp;title=Cytoreductive+surgery+and+hyperthermic+intraperitoneal+chemotherapy:+a+review+of+factors+contributing+to+morbidity+and+mortality&amp;volume=7&amp;issue=1&amp;publication_year=2016&amp;pages=99-111&amp;pmid=26941988&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r24)]

25. Eng OS, Dumitra S, O’Leary M, et al.. Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2017;152(12):1156-1160. doi: 10.1001/jamasurg.2017.2865 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831441/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/28832866)] [[CrossRef](https://doi.org/10.1001%2Fjamasurg.2017.2865)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Surg&amp;title=Association+of+fluid+administration+with+morbidity+in+cytoreductive+surgery+with+hyperthermic+intraperitoneal+chemotherapy&amp;volume=152&amp;issue=12&amp;publication_year=2017&amp;pages=1156-1160&amp;pmid=28832866&amp;doi=10.1001/jamasurg.2017.2865&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r25)]

26. Denbo JW, Bruno M, Dewhurst W, et al.. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018;164(3):424-431. doi: 10.1016/j.surg.2018.04.014 [[PMC free article](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265789/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/29807648)] [[CrossRef](https://doi.org/10.1016%2Fj.surg.2018.04.014)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Surgery&amp;title=Risk-stratified+clinical+pathways+decrease+the+duration+of+hospitalization+and+costs+of+perioperative+care+after+pancreatectomy&amp;volume=164&amp;issue=3&amp;publication_year=2018&amp;pages=424-431&amp;pmid=29807648&amp;doi=10.1016/j.surg.2018.04.014&amp;)] [[Ref list](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#zoi220380r26)]

###### Other Formats 其他格式 

- [Printer Friendly 打印机友好](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/?report=printable)

###### Actions 行动 

- Cite 引用
- Collections 收集 

Add to Collections 添加到收藏 

    - Create a new collection
    - Add to an existing collection

        Name your collection:

        Name must be less than  characters

        Choose a collection:

        Unable to load your collection due to an error

        [Please try again](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/#)

      Add

      Cancel

###### Share 共享 

- https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F&amp;text=Development%20and%20Validation%20of%20an%20Explainable%20Machine%20Learning%20Model%20for%20Major%20Complications%20After%20Cytoreductive%20...
- https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9133947%2F
- Permalink
                               固定链接 

                                      Copy 复制

###### RESOURCES 资源 

- Similar articles
                     类似文章
- Cited by other articles
                     被其他文章引用
- Links to NCBI Databases
                     链接到NCBI数据库

    [x] [x] 
    
Cite 引用 

      Copy
     复制 

      [Download .nbib 下载 .nbib 
          .nbib](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/# "Download a file for external citation management software")

  Format: 格式： 

        AMA

        APA

        MLA

        NLM

Follow NCBI 关注 NCBI 

            [Twitter](https://twitter.com/ncbi)
            [Facebook](https://www.facebook.com/ncbi.nlm)
            [LinkedIn](https://www.linkedin.com/company/ncbinlm)
            [GitHub](https://github.com/ncbi)
            https://ncbiinsights.ncbi.nlm.nih.gov/

[Connect with NLM 与 NLM 连接](https://www.nlm.nih.gov/socialmedia/index.html)

- [SM-Twitter](https://twitter.com/NLM_NIH)
- [SM-Facebook](https://www.facebook.com/nationallibraryofmedicine)
- [SM-Youtube](https://www.youtube.com/user/NLMNIH)

National Library of Medicine国家医学图书馆
                 [8600 Rockville Pike8600 罗克维尔派克
                  Bethesda, MD 20894贝塞斯达，马里兰州 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323)

[Web Policies网络政策](https://www.nlm.nih.gov/web_policies.html)
                 [FOIA信息自由法](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office)
                 [HHS Vulnerability DisclosureHHS 漏洞披露](https://www.hhs.gov/vulnerability-disclosure-policy/index.html)

[Help帮助](https://support.nlm.nih.gov/?pagename=pmc-frontend%3Apmc%3Aarticle%3A%2Farticles%2FPMC9133947%2F)
                 [Accessibility无障碍](https://www.nlm.nih.gov/accessibility.html)
                 [Careers职业机会](https://www.nlm.nih.gov/careers/careers.html)

- [NLM 自然语言管理](https://www.nlm.nih.gov/)
- [NIH NIH](https://www.nih.gov/)
- [HHS 美国卫生与公众服务部](https://www.hhs.gov/)
- [USA.gov 美国政府](https://www.usa.gov/)

External link. Please review our [privacy policy](https://www.nlm.nih.gov/privacy.html).

![](chrome-extension://fhimbbbmdjiifimnepkibjfjbppnjble/static/global/src/static/monicaLogo.png)Ctrl+M

![](chrome-extension://fhimbbbmdjiifimnepkibjfjbppnjble/static/monicaLogo.png)摘要

响应语言

中文（简体）

在此站点禁用

设置

不打开侧边栏

解释

![Tell us what you think!](./Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery - PMC_files/Feedback+Button_vt.png)

### Zahra Eftekhari 扎赫拉·阿夫特哈里 

^1^City of Hope National Medical Center, Duarte, California^1^ City of Hope National Medical Center， 杜阿尔特， 加利福尼亚州

Find articles by [Zahra Eftekhari](https://pubmed.ncbi.nlm.nih.gov/?term=Eftekhari%20Z%5BAuthor%5D)查找 Zahra Eftekhari 的文章